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ABSTRACT 
 
CAITLIN COLLINS: Understanding PECAM-1-mediated mechanotransduction:  from the 
protein to the vessel 
(Under the direction of Ellie Tzima) 
 
 
Hemodynamic forces are critical for endothelial cell (EC) function and vessel health.  
Platelet endothelial cell adhesion-1 (PECAM-1) has been identified as a critical endothelial 
mechanosensor that is required for transducing mechanical signals into intracellular 
signaling events;  however, molecular mechanisms of PECAM-1-mediated 
mechanotransduction remain elusive.  This dissertation investigates mechanosignaling and 
cellular responses directly linked to force transduction via PECAM-1. 
In recent years, there has been increasing interest to understand how cells respond 
to tension on mechanosensitive proteins.  Numerous studies investigating force-bearing 
integrins and have revealed that the cell responds to exogenous force by increasing cell-
generated force that is proportional to the applied force.  This change in cellular force 
manifests as an adaptive cellular stiffening response that allows the cell to resist the strain 
of the applied force.  While much work has focused on cellular responses linked to integrins, 
other mechanosensitive proteins are now being probed.  In Chapter II, I demonstrate that 
tension on PECAM-1 also results in an adaptive stiffening response.  Furthermore, I 
demonstrate that, surprisingly, the PECAM-1-mediated mechanoresponse is not locally 
restricted to regions proximal to the site of force application, but rather global in nature.  
These data suggest that, contrary to previous thoughts, a localized mechanical perturbation 
can globally affect signaling cascades and cellular phenotype. 
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 Mechanosensitive signaling within the endothelium is greatly influenced by the 
subendothelial matrix composition.  In Chapter III, I investigate how the extracellular matrix 
(ECM) identity influences PECAM-1 mechanosignaling and cellular response to force.  I 
demonstrate that, contrary to cells adherent on fibronectin, adhesion to collagen suppresses 
mechanical responsiveness to tension on PECAM-1, including adaptive stiffening and focal 
adhesion growth.  I further identify PKA-mediated inactivation of RhoA as critical signaling 
axis that influences endothelial cell mechanics in response to tension on PECAM-1 and the 
physiological stimulus of fluid shear stress in vitro and in vivo.  Taken together, the work 
presented in this dissertation advances our understanding of how endothelial cells integrate 
mechanical and extracellular matrix-specific cues and provides insight into how these 
factors may contribute to cellular phenotype in vivo. 
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CHAPTER I. 
Introduction 
 
 
 
Forces in biology. 
Mechanical forces influence nearly all aspects of cell behavior.  Because forces are 
central to a number of biological processes, cells are decorated with numerous 
mechanosensitive proteins that work in concert to regulate the cellular response to external 
mechanical stimuli, such as stretch or shear stress.  In addition to external forces, cells also 
generate their own forces via actomyosin-based contractility, and cell-generated forces are 
required for cellular processes, such as adhesion and maintenance of cell-cell junctions1, 2.  
In light of evidence highlighting the central role of mechanical forces in basic biological 
processes, much work has focused on understanding cellular response to force on various 
mechanosensitive proteins. 
The best characterized mechanosensors to date are tension-bearing integrins that 
couple the extracellular matrix (ECM) to the internal actin cytoskeleton.  It was first noted 
that mechanical stress applied to β1 integrins results in force-induced focal adhesion growth 
and a simultaneous force-dependent stiffening response3.  Much work over the past twenty 
years has focused on understanding the molecular mechanisms behind these observations, 
and it has become apparent that the small GTPase RhoA plays a central role in the 
regulation of the cellular response to force.  RhoA is activated downstream of tension on 
integrins via two guanine nucleotide exchange factors (GEFs), GEF-H1 and LARG4.  
Activation of the GTPase is required for both the stiffening response4 and focal adhesion 
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growth4, 5.  Other signaling molecules have also been implicated in the cellular response to 
force, as tension on integrins also elicits activation of Src6, focal adhesion kinase (FAK)4, 
and extracellular-signal related kinase (ERK)4. Inhibition of any of these kinases, as well as 
inhibition of myosin ATPase and Rho-associated protein kinase (ROCK)7, blocks stiffening, 
indicating that coordination of numerous signaling molecules is required for the cellular 
response to force.  In addition to activation of molecular signaling cascades, the force 
response also entails recruitment of signaling and structural proteins to the site of applied 
stress.  Force-dependent stiffening involves the recruitment of focal adhesion proteins such 
as β1 and β3 integrins that function to reinforce force-bearing adhesions8.  Other data 
suggest that changes in gene expression may also contribute to mechanical coupling of 
integrins with the extracellular matrix, as mRNAs and ribosomes redistribute to sites of 
mechanically stressed integrin adhesions9.  In recent years, researchers have begun to 
probe other mechanosensitive proteins such cadherins10-12 and platelet endothelial cell 
adhesion molecule-1 (PECAM-1)13.  The work in this dissertation contributes to our 
understanding of the cellular response to tension on PECAM-1. 
 
The endothelium and shear stress. 
 The endothelium is composed of a single layer of endothelial cells (ECs) that line the 
lumen of the blood vessel and form the interface between the circulating blood and 
underlying tissue.  Due to their unique location within the vessel wall, ECs are constantly 
exposed to hemodynamic forces produced by blood.  The parallel frictional force of blood 
flow, termed fluid shear stress, is a critical determinant of vessel health and disease.  
Because of the importance of hemodynamic forces in vessel health, ECs are equipped with 
numerous mechanosensitive protective that transduce the physical force of blood flow into 
various intracellular biochemical signals.   Proposed mechanosensors line all surfaces of 
ECs and include, but are not limited to:  G-protein coupled receptors (GPCRs), receptor 
	  	  
3	  
 
tyrosine kinases (RTKs), ion channels, caveolae, integrins, and a mechanosensory complex 
composed of PECAM-1, vascular endothelial (VE)-cadherin, and vascular endothelial 
growth factor receptor 2 (VEGFR2)14.  While only the apical surface of the endothelium is 
exposed to shear stress, a ‘decentralised’ model of mechanotransduction has proposed that 
the shear forces are transmitted to distant cellular sites (such as cell-cell junctions, focal 
adhesions, and the nucleus) through the actin cytoskeleton15 (Fig.1.1).  Therefore, the actin 
cytoskeleton also has a well-defined role in mechanotransduction of shear stress.  While 
signaling through many of these mechanosensors likely acts synergistically to influence the 
EC phenotype, it is important to understand the contributions of individual 
mechanoreceptors.  This dissertation will focus on PECAM-1-mediated 
mechanotransduction, described in greater detail below.   
 Endothelial responses to shear stress differ depending on the magnitude and pattern 
of blood flow.  In regions of the vessel where blood flow is low (<5 dyn/cm2) and disturbed, 
such as regions of high curvature and vessel bifurcations, ECs exist in a constitutively 
activated, proinflammatory state.  Thus, ECs in these regions display chronic activation of 
the inflammatory transcription factor nuclear kappa-light-chain enhancer of activated B cells 
(NF-κB) and augmented expression of cell adhesion molecules such as vascular cell 
adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1), which 
promote leukocyte transendothelial migration (TEM) and development of atherosclerotic 
plaques16.  Conversely, ECs in regions of the vessel that experience unidirectional, laminar 
flow often display an atheroprotective gene expression profile, including expression of anti-
inflammatory genes, such as Krüppel-like factors 2 and 4 (KLF 2/4), endothelin-1(ET-1), and 
elevated production of the vasodilator nitric oxide (NO)17.  Importantly, these regions of the 
vasculature also display relatively low incidence of atherosclerotic plaque development.  
Work from the past several decades has highlighted fluid shear stress as a critical 
determinant of atherosclerotic plaque development, although many of the molecular 
	  	  
4	  
 
mechanisms of mechanotransduction remain elusive. Thus, identifying molecular signaling 
cascades activated downstream of specific mechanosensors, such as PECAM-1, may 
reveal insights into some of the earliest events that contribute to development of disease. 
 
PECAM-1 structure and function. 
PECAM-1 is a 130 kilodalton (kD) protein that is expressed in ECs and other 
vascular cells of hematopoietic lineage, such as leukocytes and platelets.  The extracellular 
domain of the protein contains 6 immunoglobulin (Ig)-like domains that impart adhesive 
properties to the protein.  Ig-like domain 1 and 2 facilitate homophilic binding between 
PECAM-1 molecules on neighboring cells18, 19.  However, PECAM-1 has also been shown to 
function as a heterotypic ligand for other proteins, such as αvβ320.  The protein contains a 
single transmembrane domain and a relatively short cytoplasmic tail that is important for 
PECAM-1 signaling function (Fig. 1.2). The cytoplasmic tail contains two immunoreceptor 
tyrosine-based inhibitory motifs (ITIMs) that are phosphorylated upon cellular activation.  Src 
family kinase (SFK)-dependent phosphorylation of tyrosine residues Y663 and Y686 within the 
ITIM domains promote recruitment of SH2-containing proteins, such as SHP2, and lead to 
activation of downstream signaling cascades21.  Thus, although the protein has no intrinsic 
catalytic activity, PECAM-1 has been implicated in multiple intracellular signaling cascades 
by serving as a scaffold for numerous adaptor molecules.  Therefore, it is not surprising that 
PECAM-1 has a multifunctional role in vascular biology.  The protein was first identified for 
its role in leukocyte TEM22.  Later work also identified roles for PECAM-1 in angiogenesis23, 
cell survival24, 25, junctional integrity26, immune cell signaling27, 28, and shear stress 
signaling29.   
In the past decade, PECAM-1 has come to the forefront as a critical regulator of EC 
mechanotransduction.  Several studies first identified that the protein is rapidly tyrosine 
phosphorylated upon mechanical perturbation of the plasma membrane by fluid shear 
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stress30 or hyperosmotic shock31, and later work demonstrated that PECAM-1 tyrosine 
phosphorylation is mediated by the SFK Fyn32.  Tyrosine phosphorylation of the cytoplasmic 
tail results in activation of downstream signaling molecules such as ERK1/2, Akt, and 
endothelial nitric oxide synthase (eNOS)31, 33.  Work from our lab identified PECAM-1 as part 
of a mechanosensory complex with VE-cadherin and VEGFR2 that mediates several EC 
responses to shear stress, including:  activation of small GTPases34, alignment of the actin 
cytoskeleton in the direction of flow29, activation of the transcription factor NF-κB29, and flow-
mediated upregulation of cell adhesion molecules VCAM-1 and ICAM-135.  PECAM-1 also 
has clear roles in mechanotransduction in vivo, as PECAM-1-/- mice display impaired flow-
mediated dilation36, vascular remodeling35, arteriogenesis37, and altered atherosclerotic 
plaque formation38-40.  Nevertheless, while studies clearly indicate a role for PECAM-1 in 
shear stress signaling in vitro and in vivo, molecular mechanisms of PECAM-1-mediated 
mechanotransduction remain elusive. 
 
Extracellular matrix specific signaling. 
 Integrins are transmembrane receptors that couple the ECM to the internal actin 
cytoskeleton.  The mammalian genome encodes 18 α integrin subunits and 8 different β 
subunits, which give rise to 24 distinct α/β heterodimers.  Furthermore, α/β integrin 
composition dictates the ECM ligand for each heterodimer.  Within the endothelium, EC 
adhesion to the ECM is largely mediated by αvβ3 and α5β1, which bind to fibronectin (FN), 
and α2β1, which mediates adhesion to collagen (CL).   
In addition to mediating adhesion to the ECM, integrins are also activated and initiate 
signaling in response to various stimuli, including fluid shear stress41.  Importantly, shear 
stress elicits activation of divergent signaling cascades depending on the identity of the 
underlying ECM, due to signaling through diverse integrin classes.  Furthermore, integrins 
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not in contact with their permissive substrate are actively inhibited due to a mechanism of 
transdominant inhibition42.  Thus, fluid shear stress leads to activation of αvβ3 and α5β1 
(while α2β1 is inhibited) in ECs adherent on FN; whereas α2β1 is activated in ECs on CL 
(while αvβ3 and α5β1 are actively inhibited).  Furthermore, shear-induced integrin activation 
and ligation with the ECM is required for downstream signaling, such as activation of RhoA 
and alignment of the actin cytoskeleton43.  
Activation of distinct classes of integrins on disparate ECMs leads to divergent flow-
induced signaling downstream of integrins.  For instance, ECs adherent on basement 
membrane proteins such as CL and laminins (LN) display preferential activation of protein 
kinase A (PKA) and eNOS upon exposure to fluid shear stress when compared to ECs 
adherent on FN44, 45.  Conversely, shear stress preferentially activates p21-activated kinase 
(PAK)44, 46, 47, c-Jun N-terminal kinase (JNK)47, 48, and the transcription factor NF-κB when 
ECs are adherent on FN37.  Importantly, ECM-specific activation of distinct signaling 
pathways may not only influence the EC phenotype, but also the overall vessel health.  PKA 
and eNOS (which are activated on CL) are considered anti-inflammatory44, 49, while JNK and 
NF-κB have pro-inflammatory properties and have been shown to contribute to vascular 
diseases such as atherosclerosis50, 51.  
 
Mechanical and ECM heterogeneity in vivo. 
The endothelial microenvironment in vivo is complex and differs in both ECM 
composition and shear stress patterns, depending on the region of the vasculature (Fig. 
1.3).  Vessel geometry influences shear stress patterns, which are characterized by 
direction and magnitude.  Regions of the vessel that are straight and unbranched, such as 
the descending aorta, experience unidirectional laminar shear stress, ranging from 12-70 
dyn/cm2, resulting in net forward movement of blood flow52.  However, other regions of the 
vasculature under high curvature or at bifurcations or branch points are subjected to low (<5 
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dyn/cm2) and/or disturbed shear stress that is characterized by a change in flow direction 
without a net forward movement.   It has been recognized for decades that shear stress 
patterns greatly influence overall vessel health and integrity, as vascular disease such as 
atherosclerosis are highly focal and develop in regions of the vasculature, such as the aortic 
arch, that experience disturbed shear stress.  Thus, ECs in regions of vasculature that 
experience high laminar flow often display a quiescent and atheroprotective gene 
expression profile, whereas regions of the vasculature subjected to low and disturbed shear 
stress exhibit chronic activation of pro-inflammatory signaling pathways, which contribute to 
local inflammation of the vessel and atherogenesis52. 
In addition to mechanical heterogeneity, the ECM composition also differs in distinct 
regions of the vessel.  Most regions of the vasculature are rich in basement membrane 
proteins, such as collagen (types I, III, and IV) and laminins.  However, provisional matrix 
proteins, including fibronectin (FN) and fibrinogen (FG), are deposited in regions of 
disturbed and oscillatory shear stress51, 53.  As detailed in the previous section, alterations in 
the ECM composition have profound effects on EC biology and the overall health of the 
vessel.   
Atherosclerosis is a complex and highly focal disease that develops in distinct 
regions of the vasculature.  Evidence suggests that both shear stress patterns and ECM 
composition contribute to site-specific plaque development, as low and disturbed shear 
stress and FN are both associated with pro-inflammatory signaling within the endothelium.  
Furthermore, a direct relationship between shear stress patterns and ECM composition 
exists, as oscillatory shear promotes FN expression and deposition51, and increased 
subendothelial FN content sustains pro-inflammatory signaling within the endothelium in a 
positive feedback loop51. Thus, due to the complex ECM and mechanical microenvironments 
in vivo, there is a need for in vitro experiments to dissect the contribution of each factor to 
EC signaling and understand how cells integrate signals from multiple inputs to regulate 
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their function.  The work described in this dissertation sheds light on how ECs assimilate 
mechanical and ECM cues to regulate their phenotype in vitro and in vivo. 
 
EC stiffness and vascular disease. 
Several studies have identified a link between EC stiffness and decreased 
cardiovascular health.  For instance, EC stiffness (as well as vessel stiffness) often 
increases in hypertensive vessels54 and augmented EC stiffness positively correlates with 
increased permeability55.  Furthermore, increased arterial stiffness promotes atherogenic 
signaling and contributes to development of atherosclerosis56, 57.  Thus, identifying 
mechanisms of EC stiffening may have important implications for cardiovascular diseases.   
Several stimuli have been show to influence EC stiffness, including shear stress58.  
However, signaling pathways directly linking hemodynamic force to EC stiffening remain 
elusive.  Furthermore, the relationship between shear stress patterns and EC stiffness is 
complex and measurements of EC stiffness ex vivo are lacking.  The work in this 
dissertation identifies mechanisms linking hemodynamic force and EC stiffening responses 
and may provide insight into complex relationships that influence cardiovascular health in 
vivo. 	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RESEARCH PRESENTED IN THIS DISSERTATION 
 
As described in the following chapters, the goals of this dissertation are as follows: 
 
 
 
CHAPTER II:  IDENTIFY THE MOLECULAR MECHANISMS MEDIATING THE 
CELLULAR RESPONSE TO TENSION ON PECAM-1. 
 
 PECAM-1 has been identified as a critical regulator of endothelial cell 
mechanotransduction.  However, molecular mechanisms of PECAM-1 mediated 
mechanotransduction remain elusive.  In order to identify the signaling cascades and 
cellular responses directly linked to PECAM-1 mechanosignaling, I have utilized a magnetic 
tweezers system to directly apply force to PECAM-1.  Previous studies have reported an 
adaptive stiffening response following force application to other mechanosensitive proteins.  
Here, I demonstrate that tension on PECAM-1 also initiates an adaptive stiffening response.  
Furthermore, this chapter will 1)  Identify the signaling molecules that mediate the cellular 
response to tension on PECAM-1, and 2)  Determine the spatial and temporal regulation of 
the cellular response.  Finally, I demonstrate that localized tension on PECAM-1 elicits a 
global mechanotransduction response via the integrin-RhoA pathway. 
 
 
CHAPTER III:  DETERMINE HOW THE ECM COMPOSITION INFLUENCES PECAM-1-
MEDIATED MECHANOTRANSDUCTION. 
 
ECM-specific signaling is well documented within the endothelium and has profound 
effects on EC phenotype.  In this chapter, I determine how the ECM influences 
mechanosignaling and cellular responses downstream of tension on PECAM-1.  I 
demonstrate that ECs adherent on CL are less responsive to tension on PECAM-1 and do 
generate an adaptive stiffening response.  I further identify that the lack of force response is 
due to force-dependent PKA activation and subsequent inactivation of RhoA.  I further 
extend these findings to the physiological context of fluid shear stress and demonstrate that 
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force-dependent PKA activation influences EC stiffness and focal adhesion dynamics in vitro 
and in vivo. 
 
 
CHAPTER IV:  CONCLUSIONS AND PERSPECTIVES 
 
In this Chapter, I address questions raised by the work presented in Chapters II and 
III.  Furthermore, I discuss the significance of my findings in the fields of cell  and 
cardiovascular biology. Finally, I elaborate on how my findings may relate to observations 
seen in the aortic endothelium in vivo. 
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Figures 
 
Figure 1.1  Model of decentralised mechanotransduction of endothelial shear stress 
 
 
 
 
 
 
Deformation of the luminal surfaces of ECs can directly activate apical mechanosensors 
such as GPCRs, RTKs, ion channels and caveolae.  Transmission of force through cortical 
and/or filamentous actin activates mechanosensors at distal sites, such as cell-cell junctions 
and/or integrins attached to the subendothelial matrix. 
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Figure 1.2  Important domains in PECAM-1 biology 
 
 
 
 
 
 
A cartoon representing domains important for PECAM-1 function. The protein has 6 
extracellular Ig-like domains, a single pass transmembrane domain, and a relatively short 
cytoplasmic tail.   Tyrosine residues Y663 and Y686 within intracellular ITIM domains are 
phosphorylated upon cellular activation and are critical for downstream signaling. 
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Figure 1.3 Mechanical and ECM heterogeneity in vivo. 
 
  
 
 
A summary of mechanical and ECM properties in the aortic arch and descending aorta.  
Both mechanical stimuli and ECM composition influence EC signaling cascade and 
phenotypes.
	  	  
14	  
 
 
 
 
 
CHAPTER II. 
 
Localized tensional forces on PECAM-1 elicit a global mechanotransduction response 
via the integrin-RhoA pathway 
 
 
 
 
 
 
Overview  
 
Background:  Mechanical forces regulate cell behavior and function during 
development, differentiation, and tissue morphogenesis. In the vascular system, forces 
produced by blood flow are critical determinants not only of morphogenesis and function, but 
also pathological states such as atherosclerosis. Endothelial cells (ECs) have numerous 
mechanotransducers, including platelet endothelial cell adhesion molecule-1 (PECAM-1) at 
cell-cell junctions and integrins at cell-matrix adhesions.  However, the processes by which 
forces are transduced to biochemical signals and subsequently translated into downstream 
effects are poorly understood.    
Results:  Here, we examine mechanochemical signaling in response to direct force 
application on PECAM-1.  We demonstrate that localized tensional forces on PECAM-1 
result in, surprisingly, global signaling responses.  Specifically, force-dependent activation of 
phosphatidylinositol 3-kinase (PI3K) downstream of PECAM-1 promotes cell-wide activation 
of integrins and the small GTPase RhoA.   These signaling events facilitate changes in 
cytoskeletal architecture, including growth of focal adhesions and adaptive cytoskeletal 
stiffening.   
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Conclusions:  Taken together, our work provides the first evidence of a global 
signaling event in response to a localized mechanical stress. In addition, these data provide 
a possible mechanism for the differential stiffness of vessels exposed to distinct 
hemodynamic force patterns in vivo.  
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Introduction 
Mechanical forces are involved in nearly all aspects of biology 59.  Within the vascular 
system, hemodynamic forces produced by blood flow play a critical role in EC biology and 
maintenance of the vascular homeostasis.  Cells respond to mechanical stresses on 
mechanosensitive proteins, such as integrins, by employing an adaptive cellular stiffening 
response in an effort to resist increased tensile strain 3, 7, 60.  Adaptive cellular stiffening 
requires the coordination of mechanically activated signaling cascades, including the small 
GTPase RhoA and its effectors, which mediate local changes in focal adhesion growth and 
actomyosin contractility 5, 7, 61.   
Within the vascular system, ECs lining the lumen of blood vessels are positioned to 
experience constant force as a result of the shear stress of blood flow.  Hemodynamic 
forces influence EC biology and play an integral role in determining the health and integrity 
of the vessel.  To this regard, ECs are decorated with numerous mechanosensors that 
function to convert mechanical forces into defined biochemical signaling cascades.  We 
have previously identified PECAM-1 as a key endothelial mechanosensor that influences 
vessel physiology and pathology 29, 38, 39, yet insights into cellular responses directly linked to 
PECAM-1-dependent force transduction are lacking.   
Here, we use a magnetic tweezers system and a permanent ceramic magnet to 
investigate cellular responses to mechanical tension on PECAM-1.  We reveal a 
mechanotransduction pathway that involves integration of signaling between two 
mechanosensors at distinct cellular sites.  Specifically, force transduction via PECAM-1 
promotes integrin-dependent RhoA activation, leading to focal adhesion growth and 
adaptive cellular stiffening.  Furthermore, we provide evidence that local mechanical 
stimulation of PECAM-1 can initiate a global cellular response, providing new insights into 
the spatial regulation of mechanochemical signaling cascades. 
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Results  
Tensional forces on PECAM-1 result in adaptive cellular stiffening and 
mechanosignaling 
 In order to investigate mechanoresponses downstream of PECAM-1, we applied 
tensional forces, using magnetic tweezers 62, to paramagnetic beads bound to endogenous 
PECAM-1 on ECs adherent on fibronectin (FN) (Fig. S2.1A).  Brief force application 
(~100pN) revealed a typical viscoelastic-creep response similar to those seen with bead-
integrin linkages 7 (Figure S2.1B).  Application of successive pulsatile forces on PECAM-1 
resulted in a significant decrease in pulse-to-pulse bead displacement in latter pulses, 
indicative of force-dependent adaptive stiffening (Fig. 2.1A).   Furthermore, average bead 
displacement decreased approximately 40% by the end of the 2-minute time course, 
indicating a 40% increase in cell stiffness with a calculated time constant of 39.93 seconds 
(Fig. S2.1C).  Notably, bead displacement decreased without significant displacement of 
cellular organelles, such as the nucleus (Fig. S2.1D), and analysis of bead recovery 
following each pulse of force revealed a 90-95% recovery from each pulse of force (Fig. 
S2.1E), suggesting that baseline drift in bead recovery is negligible in the adaptive 
response.  Importantly, adaptive stiffening was specific to anti-PECAM-1-coated beads, as 
force application to poly-lysine-coated beads did not initiate a mechanical response 
(Supplementary Fig. S2.1F).  Previous work demonstrated activation of PI3K downstream of 
PECAM-129.  In order to examine PI3K activation in response to localized tensional forces 
on PECAM-1, magnetic beads bound to ECs expressing a GFP-PH fusion protein (which 
serves as a sensor for PI3-lipids) were subjected to force using a permanent ceramic 
magnet. Brief force application was sufficient to induce PI3K activation around anti-PECAM-
1-coated beads (Fig. 2.1B).  Recruitment around the bead was specific to PECAM-1 and not 
due to perturbation of the membrane, as ECs transfected with GFP alone (Fig. S2.1G) or 
ECs incubated with poly-lysine-coated beads (Fig. S2.1H) did not display recruitment in 
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response to force.  In order to examine if PI3K activation is required for adaptive cytoskeletal 
stiffening, pharmacological inhibitors were used to block PI3K activation.  Pretreatment of 
ECs with PI3K inhibitors, LY294002 (Fig. 2.1C) and wortmannin (data not shown), or 
inhibition of actin polymerization with Cytochalasin D (Fig. 2.1C), abolished adaptive 
stiffening, suggesting a requirement for both biochemical signaling and cytoskeletal 
remodeling.  In addition to an impaired response to mechanical force on PECAM-1, cells 
pretreated with Cytochalasin D also exhibited a decrease in basal cell stiffness, indicated by 
a significant increase in absolute bead displacement during the first pulse of force (Fig. 
S2.1I). 
 
PECAM-1-mediated adaptive stiffening is an integrin-dependent process  
 Growing evidence suggests that the integrin-extracellular matrix (ECM) adhesions 
function as sites of mechanotransduction, where upon application of external forces on 
integrins, an intracellular response is activated that leads to local focal adhesion assembly 
and associated cytoskeletal strengthening 3, 4, 60. We therefore examined if integrin ligation 
with the underlying ECM plays a role in force transmission via PECAM-1. We used a 
blocking (16G3) or nonblocking (11E5) antibody to inhibit new integrin-FN connections 
without disrupting existing adhesions 43.  Inhibition of force-induced integrin engagement 
with the FN blocking antibody attenuated PECAM-1-mediated adaptive stiffening, whereas 
the nonblocking antibody had no effect (Fig. 2.2A).  These data suggest that new integrin-
FN connections are required for adaptive stiffening, and indicate that the mechanical 
response requires input from more than one mechanosensor.   Next, we tested the 
possibility that new integrin-FN connections are required for force-induced PI3K activation.  
To this regard, inhibition of new integrin-FN connections had no effect on force-dependent 
PI3K activation (Fig. 2.2B), as ECs subjected to force showed similar levels of activation in 
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the presence of the blocking and nonblocking antibodies. These data suggest that PI3K 
activation is upstream of integrin ligation with the underlying ECM. 
 
Tensional forces on PECAM-1 activate the RhoA pathway via GEF-H1 and LARG    
Local activation of the small GTPase RhoA has been implicated in adaptive cellular 
stiffening in response to mechanical stresses on integrins 4, 7.  To investigate the role of the 
RhoA pathway in adaptive stiffening downstream of PECAM-1, ECs were pretreated with C3 
transferase or Y27632, Rho and ROCK inhibitors, respectively, prior to force application.  
Inhibition of either Rho or ROCK attenuated adaptation to force (Fig. 2.3A), suggesting a 
role for the RhoA pathway in adaptive stiffening.  We therefore hypothesized that tensional 
forces on PECAM-1 lead to RhoA activation, which is required for cytoskeletal adaptation to 
force.  To test this hypothesis, we performed Rho pulldown assays to detect levels of active 
RhoA.  ECs were incubated with anti-PECAM-1-and stimulated with continuous force 
(~10pN) using a permanent magnet for biochemical analyses.  Indeed, ECs subjected to 
tensional force on PECAM-1 displayed robust and sustained RhoA activation in response to 
force, as levels of GTP-loaded RhoA increased at 5 minutes of force application and 
remained elevated at 30 minutes of sustained force (Fig. 2.3B). Force-induced RhoA 
activation was specific to PECAM-1, as poly-lysine-coated beads did not increase levels of 
active RhoA in response to force (Fig. S2.2).  Interestingly, PECAM-1-mediated RhoA 
activation was integrin-dependent, as inhibition of new integrin-FN connections quenched 
force-induced RhoA activity (Fig. 2.3C).     
We next sought to identify the guanine nucleotide exchange factors (GEFs) that 
mediate force-induced RhoA activation by performing affinity pulldowns with a nucleotide-
free RhoA mutant (G17A) 63.  Analysis revealed a force-dependent increase in GEF-H1 and 
LARG activity, while the activity of other GEFs, such as Dbl, Vav, and Net1 were unaffected 
(Fig. 2.4A). Interestingly, these GEFs also mediate RhoA activation in response to tensional 
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forces on FN-binding integrins 4.  It was also reported that mechanical activation of GEF-H1 
relies on activation of a FAK/ERK pathway.  Previous studies have demonstrated force-
dependent activation of ERK downstream of PECAM-1 31, 32, 64.  In agreement with previous 
reports, in response to tensional forces on PECAM-1, we observed a force-dependent 
increase ERK activation, as well as FAK phosphorylation (Fig. 2.4B).  Furthermore, inhibition 
of FAK or ERK activity with pharmacological inhibitors (FAK 14 or U0126, respectively), 
attenuated force-induced GEF-H1 activation, while LARG activity was unaffected (Fig. 
2.4C).  These data suggest a common pathway employed for GEF activation in response to 
tension on diverse adhesion molecules, and, therefore, may represent a conserved 
mechanosensitive pathway.  In order to confirm a role for GEF-H1 and LARG in PECAM-1-
mediated RhoA activation, siRNAs were used to knockdown these GEFs in ECs.  Depletion 
of GEF-H1 and LARG with specific siRNAs attenuated RhoA activation and adaptive cellular 
stiffening in response to tensional forces on PECAM-1 (Fig. 2.4D,E), further supporting a 
role for these GEFs in PECAM-1-dependent stiffening.   
 
Localized tensional forces on PECAM-1 a global mechanotransduction response 
Our data suggest that force-induced RhoA activation downstream of PECAM-1 is 
integrin-dependent (Fig. 2.3C).  In order to assay integrin activation in response to tensional 
force on PECAM-1, ECs were immunostained for ligated β1 integrin (Fig. 2.5A).  
Unexpectedly, we observed a global increase in β1 integrin ligation, rather than a local 
response confined to the region proximal to the bead under tension.  This result was 
surprising, as previous studies applying tensional forces on other adhesion receptors 
demonstrated a local cellular response restricted to the site of mechanical stress 60.  Cells 
were assayed for the ratio of “global” versus “local” integrin activation, where “local” was 
defined as the region with a 5 micron radius from the site of bead attachment and the rest of 
the cell was deemed “global.”  As seen in Supplementary Figure S2.3, while total intensity of 
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activated integrin staining increased with force, the ratio of local to global integrin activation 
did not significantly change.  These data suggest that all areas of the cell can activate 
integrins to a similar level and indicate that there is no preferential localization of integrin 
activation.  
PI3K has been implicated in integrin activation in numerous cell types, including ECs 
in response to shear stress.   To this regard, pharmacological inhibition of PI3K attenuated 
PECAM-1-mediated integrin ligation with the ECM (Fig. 2.5B), suggesting that PI3K 
activation is required for global integrin activation.  We hypothesized that soluble lipid 
products produced by activated PI3K may promote cell-wide integrin activation.  Previous 
studies have employed the overexpression of a GFP-PH construct to sequester cellular 
phospholipid messengers 65, as overexpression of GFP-PH restricts the mobility of cellular 
lipid messengers and affects downstream signaling.  In order to test the hypothesis that 
mobility of PI3K lipid products is required for global integrin activation, we applied force to 
PECAM-1 on ECs overexpressing GFP-PH and assayed integrin-ECM ligation.   
Overexpression of the PH domain (which sequesters PI3K-mediated lipids) inhibited global 
integrin activation (Fig. 2.5C).  This effect was specific, as overexpression of GFP alone did 
not affect force-induced β1 integrin activation.  These data suggest that activation of PI3K 
and production of a soluble second messenger promotes global integrin activation at sites 
remote from the applied force. 
In light of our data indicating global integrin activation in response to a localized force 
on PECAM-1, we next tested if downstream RhoA activation was also a global response 
using a RhoA biosensor that detects RhoA activation via fluorescence resonance energy 
transfer (FRET) 66.  ECs transfected with the biosensor were subjected to force for the 
indicated times and fixed for subsequent FRET analysis.  Importantly, fixation did not 
significantly affect the FRET signal intensity or localization (Fig. S2.4A).  Consistent with our 
biochemical assays, we detected a statistically significant increase in RhoA activation after 5 
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minutes of force (Fig. 2.6A). A trend for increased RhoA activation remained at 30 minutes, 
but was no longer significant, as 30% of the population had returned to basal levels by this 
time point.  These results are not surprising, as it has been demonstrated that, under 
chronic force, ECs dampen activated signaling networks to maintain homeostasis.  
Importantly, a significant increase in FRET was exclusive to anti-PECAM-1-coated beads, 
as poly-lysine-coated beads did not display increased activation in response to force.  In 
agreement with the ligated β1 integrin immunostaining, ECs also displayed a remarkable 
cell-wide increase in RhoA activity in response to force on PECAM-1 (Fig. 2.6A), as RhoA 
activity increased equally in local and global regions of the cell (Fig. S2.4B). In contrast to 
PECAM-1, tensional forces on FN-binding integrins did not induce global RhoA activation 
(data not shown). 
Adaptive cellular stiffening is mediated, in part, by a local increase in focal adhesions 
at the site of mechanical stress that function to resist the applied force 5, 8, 67.  To further 
explore the possibility that localized force on PECAM-1 could lead to a global cellular 
response, we assessed focal adhesion growth by immunostaining for the focal adhesion 
marker vinculin.  Remarkably, ECs exhibited a cell-wide increase in focal adhesion number, 
as well as individual focal adhesion size in response to tensional forces on PECAM-1 (Fig. 
2.6B). These results further support the notion that a local force on PECAM-1 promotes a 
global signaling and cytoskeletal response.  
 
Discussion 
The present study provides insights into a mechanochemical signaling pathway 
downstream of PECAM-1 that relies on signals from multiple inputs, including 
mechanosensors at other transduction sites, such as integrins (Fig. 2.6C).  We propose that 
force application on PECAM-1 results in PI3K activation, which leads to global activation of 
integrins and subsequent global RhoA activation via GEF-H1 and LARG.  Activation of the 
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GTPase promotes changes in cytoskeletal organization, including adaptive stiffening of the 
cytoskeleton and a cell-wide growth of focal adhesions. Using pharmacological inhibitors, 
we show that numerous signaling molecules work in concert to facilitate adaptive cellular 
stiffening.  Interestingly, cells treated with cytoskeletal inhibitors (Cytochalasin D, C3, and 
Y27632) are immediately impaired and cannot respond to force (pulses 2-11, Figs. 2.1C, 
2.3A), whereas inhibition of new FN-integrin connections does not impair the mechanical 
response until latter pulses (pulses 5-11, Fig. 2.2A).  These data suggest that pre-existing 
tension within the cytoskeleton is required for the immediate response to force, while new 
FN-integrins interactions are required for strengthening of adhesions and adaptive stiffening.  
At the present time it is difficult to determine if adaptive stiffening is a cell-wide phenomenon 
or a local event that occurs proximal to the site of force application.  However, a global 
increase in focal adhesion size and number suggests that regions of the cell distal from the 
site of mechanical stress are responsive to exogenous force.   
Previous studies probing integrins reported rapid mechanosignaling propagated 
through tensile cytoskeletal elements to remote cytoplasmic locations away from the site of 
mechanical stress 6, 68, 69.  However, these signals were not global and diffuse, but rather 
confined to distinct foci that corresponded with sites of cytoskeletal deformation. Thus, we 
provide the first evidence of a global signaling event in response to a localized mechanical 
stress.  
While PECAM-1 has not been shown to directly interact with the cytoskeleton, 
indirect association via cytoplasmic interactions with β-catenin and γ-catenin have been 
proposed70, 71.  Although we cannot rule out that mechanical signaling through tensile 
cytoskeletal elements may contribute to PECAM-1-mediated mechanotransduction, our data 
suggest that chemical signaling (via activated PI3K) is required for a global cellular 
response, such as integrin activation.   We also observed a delayed cellular stiffening 
response following force application on PECAM-1 compared to the immediate stiffening 
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response reported when probing integrins 4, 7.  This delayed response further suggests 
involvement of a chemical signaling component, as an exclusively mechanical response 
would be expected to occur on a millisecond timescale. Future studies with PECAM-1 
cytoplasmic tail truncation mutants may provide insight into the relative contributions of 
mechanical and chemical signaling components in adaptive stiffening. 
Our study also highlights cooperation of two mechanosensors (PECAM-1 and 
integrins) in the EC response to force.  Previous studies have highlighted a complex 
relationship between PECAM-1 and integrins.   PECAM-1/PECAM-1 homophilic 
engagement can upregulate function of β1 integrins in numerous cell types.  Crosslinking of 
PECAM-1 on specific subsets of T-lymphocytes increases β1–mediated adhesion 72.  In 
addition, engagement of PECAM-1 on platelets increases integrin-dependent adhesion and 
aggregation 73.  Our data suggest that PECAM-1-mediated mechanosensing may also 
promote β1–mediated adhesion in ECs, as tension on PECAM-1 initiates β1 ligation with the 
underlying extracellular matrix.  Furthermore, β1 integrin engagement has also been shown 
to mediate tyrosine dephosphorylation of the cytoplasmic tail of PECAM-1, which may 
influence PECAM-1-mediated signaling 74.  Therefore, it is possible that a complex feedback 
loop may be present in our system.  Importantly, a complex relationship between PECAM-1 
and αvβ3 also exists.  αvβ3 serves as a heterotypic ligand for PECAM-1, and interaction 
between these proteins may be important for endothelial functions such as leukocyte 
transendothelial migration and angiogenesis 20.  While we focus on the β1 integrin subtype, 
αvβ3 integrins may also contribute to the EC response to force.  At the present time, we 
cannot differentiate the contribution of the different FN-binding integrin subtypes to the 
cellular response to tension on PECAM-1.  However, previous studies have implicated a role 
for α5β1 clustering in the formation of adhesions that experience strong matrix forces, while 
αvβ3 integrin heterodimers strengthen integrin-cytoskeleton linkages in a talin-dependent 
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manner 75.  Therefore, it is likely that multiple integrin subtypes may also be involved in 
PECAM-1-mediated mechanotransduction. 
Atomic force microscopy (AFM) studies have revealed that ECs in regions of the 
vasculature that experience disturbed hemodynamics, and are thus predisposed to 
development of atherosclerotic plaques, exhibit increased stiffness when compared to ECs 
in healthy regions of the vessel 76.  Interestingly, regions of disturbed shear stress are also 
rich in FN deposition 53, 77, which, we now show, promotes a stiffer cellular phenotype.  
Therefore, our work may provide insights into early signaling events that contribute to 
cellular stiffening and plaque development. 
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Figures 
 
Figure 2.1 Tensional forces on PECAM-1 result in adaptive cellular stiffening and PI3-
kinase activation.  
 
 
(A) Schematic of experimental design.  Two-second pulses of force (~100 pN) separated by 
10-second intervals over a 2-minute time course. Representative example of bead 
displacement in response to the pulsatile force regimen.  Stiffening is indicated by 
decreased displacement during latter pulses. (B) ECs expressing GFP-PH were incubated 
with anti-PECAM-1-coated magnetic beads and subjected to force with a permanent 
ceramic magnet for the indicated times.  Cells were fixed and scored for GFP-PH 
recruitment around the bead (box).  Location of the bead is highlighted by the yellow circle 
(n > 50 cells/condition from 3 independent experiments;  scale bar = 10µm). (C) Average 
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relative anti-PECAM-1 bead displacements induced by the pulsatile force regimen.  In some 
experiments, cells were pretreated with LY294002 (30µM for 20 min) or Cytochalasin D 
(10µM for 30 min) prior to incubation with magnetic beads.  Average displacements were 
calculated relative to the first pulse of force. (n >15 beads/condition from 3 independent 
experiments).  Error bars represent s.e.m., *p<0.05.  
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Figure 2.2  PECAM-1-mediated adaptive cellular stiffening, but not PI3K activation, is 
integrin-dependent.  
 
(A) ECs were incubated with 20µg/ml of FN blocking (16G3) or nonblocking antibody (11E5) 
for 20 min prior to force application. Average displacements were calculated relative to the 
first pulse of force to anti-PECAM-1-coated beads (n > 15 beads/condition from 3 
independent experiments) (B) ECs expressing GFP-PH were incubated with 16G3 or 11E5 
(20µg/ml, 20min) antibodies prior to being subjected to force with a permanent ceramic 
magnet. Cells were fixed and scored for GFP-PH recruitment around the bead (n > 50 
cells/condition from 3 independent experiments; scale bar = 10µm). Error bars represent 
s.e.m., *p<0.05.
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Figure 2.3  Tensional forces on PECAM-1 activate the RhoA pathway.  
 
 
(A)  Adherent ECs were incubated with anti-PECAM-1-coated magnetic beads and 
subjected to pulsatile tensional forces.  For some conditions, cells were pretreated with C3 
(2.0µg/ml, 2hrs) or Y27632 (5µM, 10min) prior to force application. Average displacements 
were calculated relative to the first pulse of force. (n>15 cells/condition from 3 independent 
experiments).  Error bars represent s.e.m., *p<0.05.  (B-C)  ECs were incubated with anti-
PECAM-1-coated beads and subjected to force with a permanent ceramic magnet for the 
indicted times (B)  Active RhoA (RhoA-GTP) was isolated with GST-RBD and analyzed by 
western blot (n=5).  (C)  ECs were incubated with 20µg/ml of FN blocking (16G3) or 
nonblocking antibody (11E5) for 20 min prior to force application.  Active RhoA (RhoA-GTP) 
was isolated with GST-RBD and analyzed by western blot (n=3).   Blots (B, C) are 
representative of at least 3 independent experiments.   
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Figure 2.4  Tensional forces on PECAM-1 elicit RhoA activation and adaptive cellular 
stiffening via GEF-H1 and LARG.  
 
 
(A-D)  Cells were incubated with anti-PECAM-1 coated magnetic beads and tension was 
applied for the indicated times using a permanent ceramic magnet.   (A) Cells were lysed 
and active GEFs were precipitated with GST-(G17A)RhoA and analyzed by western blot 
(n=3), (B) Cells were lysed, subjected to SDS-PAGE, and immunoblotted with indicated 
antibodies.  Blots are indicative of 3 independent experiments.  (C) Cells were lysed and 
active GEFs were precipitated with GST-(G17A)RhoA and analyzed by Western blot (n=3).  
For some conditions, cells were pretreated with FAK inhibitor 14 (5µM, 30min) or U0126 
(5µM, 30min) to inhibit FAK and ERK, respectively (n=3). (D,E)  siRNA-transfected ECs 
were incubated with anti-PECAM-1-coated beads and subjected to force for the indicated 
times. Active RhoA was isolated with GST-RBD and analyzed by western blot (n=3).  All 
blots (A-D) are indicative of at least 3 independent experiments. (E)  siRNA-transfected ECs 
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on FN were incubated with anti-PECAM-1-coated magnetic beads and subjected the 
pulsatile force regimen using magnetic tweezers. Average displacements were calculated 
relative to the first pulse of force (n >15 beads/condition from 3 independent experiments, 
*p<0.05). 
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Figure 2.5  Local tensional forces on PECAM-1 elicit global β1 integrin activation.   
 
 
(A) ECs were incubated with anti-PECAM-1-coated beads (4.5µm) and subjected to force 
with a permanent ceramic magnet for the indicated times.  ECs were fixed and stained with 
HUTS-4, which recognizes ligated β1 integrin, and phalloidin to mark the actin cytoskeleton.  
(n > 30 cells/condition from 3 independent experiments; scale bar = 10µm, *p<0.05, 
**p<0.02).  (B)  ECs were incubated with anti-PECAM-1-coated beads (4.5µm)  and 
subjected to force for the indicated times.  ECs were fixed and stained for activated β1 
integrins and the actin cytoskeleton.  Cells were pretreated with LY294002 (30µM, 20min) to 
inhibit PI3K activation prior to force application (n > 25 cells/condition from 3 independent 
experiments; scale bar = 10µm, *p<0.05).  (C) ECs overexpressing GFP or GFP-PH were 
incubated with anti-PECAM-1-coated beads (4.5µm) and force was applied.  ECs were fixed 
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and stained for activated β1 integrins (n > 25 cells/condition from 3 independent 
experiments, *p<0.05).    For all panels, integrin activation was quantified using thresholded 
images and ImageJ software.  Values were normalized to the “No Force” condition.   Error 
bars represent s.e.m.  
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Figure 2.6  Local tensional forces on PECAM-1 elicit global RhoA activation and 
adhesion growth.   
 
(A) ECs expressing the RhoA biosensor were incubated with poly-lysine or anti-PECAM-1-
coated beads (4.5µm) and subjected to force with a permanent ceramic magnet for the 
indicated times.  Cells were fixed and analyzed for FRET.  Whole cell FRET ratios were 
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calculated for each condition.  Autofluorescent beads are highlighted in black dotted circles 
(n > 45 cells/condition from 4 independent experiments, *p < 0.05).  (B) Adherent ECs on 
FN were incubated with anti-PECAM-1-coated magnetic beads and subjected to force for 
the indicated times.  ECs were fixed stained with phalloidin and an anti-vinculin antibody to 
mark focal adhesions. Focal adhesion number and size were quantified using NIH ImageJ 
software.  Values were normalized to the “No Force” condition.  Location of the beads are 
highlighted in yellow circles (n > 30cells/condition from 3 independent experiments, *p < 
0.05, scale bar = 10µm). (C) Model of PECAM-1-mediated mechanotransduction. Local 
tensional forces on PECAM-1 results in global mechanosignaling and changes in 
cytoskeletal architecture.   
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Experimental Procedures 
Cell culture, reagents, and antibodies.  Bovine aortic endothelial cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM, CellGro) with 10% fetal bovine serum, and 
1% penicillin/streptomycin solution. Cells were plated on fibronectin (10µg/ml) 4 hours prior 
to experiments.  LY294002, Cytochalasin D, wortmannin, and Y27632 were purchased from 
Calbiochem.  Cell permeable C3 transferase was purchased from Cytoskeleton. The 
PECAM-1 antibody (PECAM 1.3) was a generous gift from D.K. Newman (BloodCenter of 
Wisconsin).  Integrin blocking (16G3) and nonblocking (11E5) antibodies were kindly 
provided by K. Yamada (NIH).  The LARG antibody was a generous gift from Kozo Kaibuchi 
(Nagoya University, Japan).  Antibodies to RhoA (26C4) and Dbl (sc-89) were purchased 
from Santa Cruz Biotechnologies. The GEF-H1 was from Cell Signaling and the antibody to 
Vav was from BD Transduction. The antibody to Net1 was obtained from Abcam and the 
vinculin antibody was purchased from Sigma.  The HUTS-4 antibody (which recognizes 
ligated β1 integrin) was purchased from Millipore. 
 
Transfections and RNA interference.  For GFP-PH and FRET experiments, cells were 
seeded at 50% confluence and transfected with 2.5µg of the GFP-PH construct or RhoA 
biosensor using Effectene reagents (Qiagen) according to the manufacturer’s protocol and 
experiments were performed 48 hours after transfection.  For RNA interference 
experiments, control (Dharmacon siGLO RISC-free control siRNA), GEF-H1, or LARG 
siRNAs (Dharmacon) were transfected into cells using DharmaFECT4 (Dharmacon), 
according to the manufacturer’s instructions.  Cells were plated on FN 72 hours post-
transfection and experiments were performed.  The following siRNA sequences were used 
in this study:  GEF-H1:  5’- AGACAGAGGAUGAGGCUUAUU -3’; and LARG: 5’- 
GGGAAUAUGGAGAGAAUUAUU- 3’. 
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Preparation of beads.  Tosyl-activated paramagnetic beads (2.8 or 4.5 micron, Invitrogen) 
were washed with PBS and coated with an anti-PECAM-1 antibody (PECAM 1.3) or poly-
lysine solution (Sigma) according to the manufacturer’s instructions. Beads were quenched 
in 0.2M Tris prior to use to remove any remaining tosyl group and resuspended in DMEM 
containing 10% fetal bovine serum and 1% penicillin/streptomycin solution.  Immediately 
before experiments ECs were incubated with beads (2-6 beads/cell) for 30 min at 37°C.  
Cells were briefly washed with fresh media to remove unbound beads prior to force 
application. 
 
Pulsatile force application.  The UNC 3D Force Microscope (3DFM) was used to apply 
controlled pulsatile forces (~100pN) to anti-PECAM-1-coated magnetic beads (2.8µm 
diameter).  Bead displacements were recorded with a high-speed video camera (Pulnix, JAI) 
and tracked using Video Spot Tracker (Center for Computer Integrated Systems for 
Microscopy and Manipulation).  Cells were monitored for changes in morphology, movement 
of the nucleus, cell edges, and particulates.  No significant changes in cell morphology or 
movement of organelles were noticeable.   
 
Permanent force application.  For all immunostaining and biochemical analyses, 
continuous force (~10pN) was applied to anti-PECAM-1-coated beads (4.5µm diameter) 
using a permanent ceramic magnet (K&J Magnetics) parallel to the culture dish surface at a 
distance of 1cm from the adherent cells.  No significant changes in cell morphology or 
movement of the nucleus, cell edges, or organelles was noticeable. 
 
Immunofluorescence.  To examine activation of PI3K, GFP-PH-transfected cells subjected 
to force (permanent magnet, 4.5µm beads) were fixed for 20 min in PBS containing 2% 
formaldehyde and mounted in Vectashield mounting medium (Vector laboratories).  For all 
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other experiments, cells were fixed for 20 min in PBS containing 2% formaldehyde, 
permeabilized with 0.2% Triton X-100, and blocked with PBS containing 10% goat serum for 
1hr at room temperature.  Antibody incubations were performed as previously described 62 
and mounted in Vectashield mounting medium.  Images were acquired using a confocal 
microscope (Olympus FV500) with a 63× oil lens.  
 
GST-RBD and GST-RhoA(G17A).  Adherent cells were incubated with anti-PECAM-1-
coated beads (4.5 micron, Invitrogen) for 30 min and subjected to force for indicated times.  
Active RhoA pulldowns were performed as previously described78. Briefly, following force 
application, cells were lysed in 50mM Tris (pH 7.6), 500mM NaCl, 1% Triton X-100, 0.1% 
SDS, 0.5% deoxycholate, 10mM MgCl2, and protease inhibitors.  Anti-PECAM-1-coated 
magnetic beads were removed from lysates with a magnetic separator.  Lysates were 
centrifuged for 5min and supernatants were transferred to a new tube and incubated at 4° 
with 80µg of purified (GST-RBD) bound to glutathione-sepharose beads.  Bead pellets were 
washed in 50mM Tris (pH 7.6), 150mM NaCl, 1% Triton X-100, 10mM MgCl2, and protease 
inhibitors, and subsequently resuspended in Laemmli sample buffer and subjected to SDS-
PAGE.  Precipitation of active GEFs with the nucleotide-free RhoA mutant (G17A) were 
performed as previously described63.  Briefly, following force application cells were lysed in 
20mM HEPES (pH 7.6), 150mM NaCl, 1% Triton X-100, 5mM MgCl2, and protease 
inhibitors.  Lysates were incubated at 4°C for 45 minutes with 100µg of purified GST-G17A 
RhoA bound to glutathione-sepharose beads.  Pelleted beads were then wash in lysis 
buffer, resuspended in Laemmli sample buffer, and subjected to SDS-PAGE. 
 
FRET analysis.  RhoA activation was measured by FRET in fixed cells by monitoring the 
ratio of FRET (ECFP excitation and Citrine emission) to ECFP emission (ECFP excitation 
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and emission) as previously described51,64. Cells were chosen for similar, low expression 
levels. Single-frame images were acquired on an inverted epifluorescence microscope 
(model IX81; Olympus), using a 40X UPlan FLN 1.3 N/A DIC lens (Olympus), a CCD 
camera (CoolSnapESII; Roper Industries), and MetaMorph software (Universal Imaging). 
For emission ratio imaging, the following filter sets were used (Chroma Technology Corp.): 
CFP: D436/20, D470/40; FRET: D436/20, HQ535/30; YFP: HQ500/20, HQ535/30. A 
dichroic mirror was custom-manufactured by Chroma for compatibility with all of these filters. 
Cells were illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral density filter. At 
each time point, three images were recorded with the following exposure times: CFP (1.2 s) 
and FRET (0.6 s)   
Metamorph software was used to perform image analysis. All images were first shading-
corrected and background-subtracted. The FRET image, because it had the largest signal-
to-noise ratio and therefore provided the best distinction between the cell and the 
background, was thresholded to generate a binary mask with a value of zero outside the cell 
and a value of one inside the cell. After multiplication by this mask, the FRET image was 
divided by the CFP image to yield a ratio image reflecting RhoA activation throughout the 
cell. A linear pseudocolour lookup table was applied, and the ratio values were normalized 
to the lower scale value which was chosen to exclude the bottom 5% of the total histogram 
distribution, thereby avoiding spurious low intensity pixels. In each experiment, all images 
were inspected to verify that all portions used to create the ratio image had a sufficiently 
high signal-to-noise ratio. We targeted at least 300 gray level values (12-bit dynamic range) 
above background in the lowest intensity regions within the cell (S/n > 3). This was 
especially important in thin parts of the cell where fluorescence was low. The ratio was 
corrected for bleaching. 
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Whole-Cell FRET Analysis.  To calculate whole-cell average FRET ratio for the 
determination of the effects of mechanical force on RhoA activation, FRET ratio (FRET/CFP) 
images acquired and processed as described above were loaded into Metamorph, 
thresholded to generate masks for each cell, and regions were drawn around each cell 
using the mask.  From these regions, a number of parameters, including average pixel 
intensity, could be measured and recorded.  Average FRET ratio intensity was calculated for 
each image for at least 10 cells per condition and averaged for each treatment condition.   
 
Quantification of integrin activation and focal adhesions.  ECs stained for ligated β1 
integrin- or vinculin were analyzed with NIH ImageJ software.  Confocal image planes at the 
basal surface of the cell were chosen for analysis and RGB images were converted to 8-bit 
black and white images.  Activated integrins and focal adhesions were defined by setting an 
intensity threshold to remove any background signal.  Integrin activation and focal adhesion 
size and number were analyzed using the ‘Analyze particles’ function.  
 
Statistical analysis.  Data are presented as means ± s.e.m. p-values were determined 
using a two-tailed unpaired Student’s t-test. 
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Supplemental Figures 
 
Supplementary Figure 2.1  Characterization of the cellular response to tension on 
PECAM-1.   
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(A)  A representative image of endogenous PECAM-1 trapped around an anti-PECAM-1-
coated bead.  ECs were fixed and stained for PECAM-1 to visualize recruitment of 
endogenous PECAM-1 around the bead.  (B) Representative bead displacement of an anti-
PECAM-1 coated bead during a 100pN, 2 second pulse of force (black line).  (C) The 
PECAM-1-mediated stiffening response time constant was calculated by fitting the percent 
of maximum response to the exponential function 1-e^(-t/T).  Maximum response was taken 
to be a 40% reduction in displacement relative to the first pull.  (D)  Nuclei of cells with 
PECAM-1-coated beads under tension were analyzed for movement over a 2-minute time 
course using Video Spot Tracker software.  Average movement of 20 nuclei during the 
experiment (green) is not significant or pulsatile when compared to a representative 
PECAM-1-coated bead (blue). (E)  ECs were incubated with PECAM-1-coated beads.  Two-
second pulses of force (~100 pN) separated by 10-second intervals over a 2-minute time 
course.  Recovery from each pulse of force was calculated and plotted over time.  Fitted line 
indicates a 90-95% recovery from each pulse of force and negligible baseline drift in bead 
movement.  (F) Adherent ECs were incubated with anti-PECAM-1-coated or poly-lysine-
coated magnetic beads and subjected to pulsatile tensional forces.  Average displacements 
were calculated relative to the first pulse of force. (n>15 cells/condition from 3 independent 
experiments).  Error bars represent s.e.m., *p<0.05.  (G)  ECs expressing GFP were 
incubated with anti-PECAM-1-coated magnetic beads and subjected to force for the 
indicated times.  Cells were fixed and scored for GFP recruitment around the bead.  Bead 
location is indication by dotted yellow circle (n > 30 cells/condition from 3 independent 
experiments;  scale bar = 10µm).  (H)  ECs expressing GFP-PH were incubated with poly-
lysine-coated magnetic beads and subjected to force for the indicated times.  Cells were 
fixed and scored for GFP-PH recruitment around the bead.  Bead location is indicated by 
dotted yellow circle (n > 45 cells/condition from 3 independent experiments;  scale bar = 
10µm).  (I) Average displacements of anti-PECAM-1-coated beads.  ECs in each 
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experimental condition were incubated with anti-PECAM-1-coated beads and subjected to 
pulsatile force.  Bead displacement during the first pulse of force was calculated for each 
condition.  Error bars represent s.e.m., n > 15 cells/condition, and *p<0.05. 
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Supplementary Figure 2.2  Force-induced RhoA activation is specific to PECAM-1.  
 
 
ECs were incubated with poly-lysine-coated beads and subjected to force for the indicted 
times.  Some cells were treated with thrombin as a positive control.  Active RhoA (RhoA-
GTP) was isolated with GST-RBD and analyzed by western blot.  Blot is representative of 3 
independent experiments. 
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Supplementary Figure 2.3  Characterization of the global integrin activation.   
 
ECs were incubated with anti-PECAM-1-coated beads and subjected to force for the 
indicated times.  ECs were fixed and stained for activated β1 integrins.  Images acquired at 
the cell-ECM interface were analyzed using ImageJ software.  Staining within a 5um radius 
from the site of bead attachment was deemed “local”, while the remaining cell area (more 
than 5um away from the bead) was classified as “global.”  (n > 15 cells per condition from 3 
independent experiments; error bars represent s.e.m.; p < 0.05)   
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Supplementary Figure 2.4  Characterization of global RhoA activation.   
 
 
(A)  Images were acquired and analyzed for FRET in living ECs expressing the RhoA 
biosensor.  Cells were fixed and subsequently analyzed for FRET post-fixation.  Whole cell 
FRET ratios were calculated for each condition (n=8 cells).  Images are representative of a 
cell pre- and post-fixation.  Relative whole cell FRET ratios before and after fixation were 
calculated.  Errors bars are representative of s.e.m.  (B)  ECs expressing the RhoA 
biosensor were incubated with PECAM-1-coated beads and subjected to force for the 
indicated times.  Cells were fixed and analyzed for FRET.  Whole cell FRET ratios were 
calculated for each condition.  FRET intensity was determined using ImageJ software.  
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Signal within a 5um radius from the site of bead attachment was deemed “local”, while the 
remaining cell area (more than 5um away from the bead) was classified as “global.”  (n > 15 
cells per condition from 3 independent experiments; error bars represent s.e.m.; p < 0.05). 
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Supplemental Experimental Procedures. 
Cell culture, reagents, and antibodies.  Bovine aortic endothelial cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM, CellGro) with 10% fetal bovine serum, and 
1% penicillin/streptomycin solution. Cells were plated on fibronectin (10µg/ml) 4 hours prior 
to experiments.  The HUTS-4 antibody (which recognizes ligated β1 integrin) was purchased 
from Millipore. 
 
Transfections and RNA interference.  For GFP-PH and FRET experiments, cells were 
seeded at 50% confluence and transfected with 2.5µg of the GFP-PH construct or RhoA 
biosensor using Effectene reagents (Qiagen) according to the manufacturer’s protocol.   
 
Preparation of beads.  Tosyl-activated paramagnetic beads (Invitrogen) were washed with 
PBS and coated with a PECAM-1 antibody or poly-lysine solution (Sigma) according to the 
manufacturer’s instructions. Beads were resuspended in DMEM containing 10% fetal bovine 
serum and 1% penicillin/streptomycin solution.  Immediately before experiments ECs were 
incubated with beads (2-6 beads/cell) for 30 min at 37°C.  Cells were briefly washed with 
fresh media to remove unbound beads prior to force application. 
 
Pulsatile force application.  The UNC 3D Force Microscope (3DFM) was used to apply 
controlled pulsatile forces (~100pN) to anti-PECAM-1-coated magnetic beads (2.8µm 
diameter).  Bead displacements were recorded with a high-speed video camera (Pulnix, JAI) 
and tracked using Video Spot Tracker (Center for Computer Integrated Systems for 
Microscopy and Manipulation).  Cells were monitored for changes in morphology, movement 
of the nucleus, cell edges, and particulates.  No significant changes in cell morphology or 
movement of organelles were noticeable.   
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Permanent force application.  For all immunostaining and biochemical analyses, 
continuous force (~10pN) was applied to anti-PECAM-1-coated beads (4.5µm diameter) 
using a permanent ceramic magnet (K&J Magnetics) parallel to the culture dish surface at a 
distance of 1cm from the adherent cells.  No significant changes in cell morphology or 
movement of the nucleus, cell edges, or organelles was noticeable. 
 
Immunofluorescence.  To examine activation of PI3K, GFP-PH or GFP-transfected cells 
subjected to force were fixed for 20 min in PBS containing 2% formaldehyde and mounted in 
Vectashield mounting medium (Vector laboratories).  Antibody incubations were performed 
as previously described 62 and mounted in Vectashield mounting medium.  Images were 
acquired using a confocal microscope (Olympus FV500) with a 63× oil lens. 
 
Calculation of the time constant.  The response time constant was calculated by fitting the 
percent of maximum response to the exponential function 1-e^(-t/T).  Maximum response 
was taken to be a 40% reduction in displacement relative to the first pull.  Time in seconds 
was the time after the beginning of the first pull.  Curve fitting was done using the 
Levenberg-Marquardt algorithm in KaleidaGraph (Synergy Software).  Tau was determined 
to be 39.9 s.  This corresponds to a t1/2 of 27.7 sec.   
 
GST-RBD.  Adherent cells were incubated with PECAM-1 coated beads (4.5 micron, 
Invitrogen) for 30 min and subjected to force for indicated times.  Active RhoA pulldowns 
were performed as previously described78. Briefly, following force application, cells were 
lysed in 50mM Tris (pH 7.6), 500mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% 
deoxycholate, 10mM MgCl2, and protease inhibitors.  Anti-PECAM-1-coated magnetic beads 
were removed from lysates with a magnetic separator.  Lysates were centrifuged for 5min 
and supernatants were transferred to a new tube and incubated at 4° with 80µg of purified 
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(GST-RBD) bound to glutathione-sepharose beads.  Bead pellets were washed in 50mM 
Tris (pH 7.6), 150mM NaCl, 1% Triton X-100, 10mM MgCl2, and protease inhibitors, and 
subsequently resuspended in Laemmli sample buffer and subjected to SDS-PAGE.   
 
FRET analysis.  RhoA activation was measured by FRET in live and fixed cells by 
monitoring the ratio of FRET (ECFP excitation and Citrine emission) to ECFP emission 
(ECFP excitation and emission) as previously described51,64. Cells were chosen for similar, 
low expression levels. Single-frame images were acquired on an inverted epifluorescence 
microscope (model IX81; Olympus), using a 40X UPlan FLN 1.3 N/A DIC lens (Olympus), a 
CCD camera (CoolSnapESII; Roper Industries), and MetaMorph software (Universal 
Imaging). For emission ratio imaging, the following filter sets were used (Chroma 
Technology Corp.): CFP: D436/20, D470/40; FRET: D436/20, HQ535/30; YFP: HQ500/20, 
HQ535/30. A dichroic mirror was custom-manufactured by Chroma for compatibility with all 
of these filters. Cells were illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral 
density filter. At each time point, three images were recorded with the following exposure 
times: CFP (1.2 s) and FRET (0.6 s)  Metamorph software was used to perform image 
analysis. All images were first shading-corrected and background-subtracted. The FRET 
image, because it had the largest signal-to-noise ratio and therefore provided the best 
distinction between the cell and the background, was thresholded to generate a binary mask 
with a value of zero outside the cell and a value of one inside the cell. After multiplication by 
this mask, the FRET image was divided by the CFP image to yield a ratio image reflecting 
RhoA activation throughout the cell. A linear pseudocolour lookup table was applied, and the 
ratio values were normalized to the lower scale value which was chosen to exclude the 
bottom 5% of the total histogram distribution, thereby avoiding spurious low intensity pixels. 
In each experiment, all images were inspected to verify that all portions used to create the 
ratio image had a sufficiently high signal-to-noise ratio. We targeted at least 300 gray level 
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values (12-bit dynamic range) above background in the lowest intensity regions within the 
cell (S/n > 3). This was especially important in thin parts of the cell where fluorescence was 
low. The ratio was corrected for bleaching using a method. 
 
Whole-Cell FRET Analysis.  To calculate whole-cell average FRET ratio for the 
determination of the effects of mechanical force on RhoA activation, FRET ratio (FRET/CFP) 
images acquired and processed as described above were loaded into Metamorph, 
thresholded to generate masks for each cell, and regions were drawn around each cell 
using the mask.  From these regions, a number of parameters, including average pixel 
intensity, could be measured and recorded.  Average FRET ratio intensity was calculated for 
each image for at least 10 cells per condition and averaged for each treatment condition.   
 
Analysis of β1 integrin localization.  ECs stained for ligated β1 integrin were analyzed with 
NIH ImageJ software.  Confocal images at the basal surface of the cell were chosen for 
analysis and RGB images were converted to 8-bit black and white images.  Integrin 
activation was defined by setting an intensity threshold to remove background signal.  
Integrin activation was analyzed using the ‘Analyze particles’ function. To calculate “global” 
versus “local” integrin activation, signal within a 5um radius from the site of bead attachment 
was deemed “local”, while the remaining cell area (more than 5um away from the bead) was 
classified as “global.”  Fluorescence intensity in each region of the cell was quantified using 
ImageJ software. 
 
Analysis of RhoA FRET localization.  ECs expressing the RhoA biosensor were analyzed 
using NIH ImageJ software.  Images acquired with an epifluourescence microscope 
(Olympus Ix81) were converted to 8-bit black and white images.  To calculate “global” 
versus “local” RhoA FRET, signal within a 5um radius from the site of bead attachment was 
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deemed “local”, while the remaining cell area (more than 5um away from the bead) was 
classified as “global.”  Fluorescence intensity in each region of the cell was quantified using 
ImageJ software. 
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CHAPTER III. 
Hemodynamic and extracellular matrix cues regulate the mechanical phenotype and 
stiffness of endothelial cells 
 
 
Overview  
Mechanical forces produced by blood flow influence blood vessel physiology and 
pathology.  Endothelial cell (ECs) lining the lumen of the blood vessel are decorated with 
numerous mechanoreceptors, including platelet endothelial cell adhesion molecule-1 
(PECAM-1), that function to convert mechanical force to intracellular biochemical signals.  
While it is accepted that mechanical stresses and the mechanical properties of the cells 
regulate vessel health, the relationship between force and biological response remains 
elusive. Here, we show that cells integrate external mechanical force and ECM cues to 
dynamically modulate their own mechanical properties. Using a magnetic tweezers system, 
we demonstrate that the cellular response to mechanical tension on PECAM-1 depends on 
the identity of the ECM. While some responses are common, ECs adherent on collagen 
display divergent stiffening and focal adhesion dynamics compared to ECs on fibronectin. 
Mechanistically, this is due to collagen-dependent mechanosensitive PKA activation, Ser188 
RhoA phosphorylation, and inhibition of RhoA. We further extend these studies and show 
that this pathway regulates focal adhesion dynamics in ECs in vitro in response to shear 
stress and in vivo in the hemodynamic environment of the vessel. Finally, passive 
microbead rheology studies suggest that the PKA pathway is responsible for maintaining 
low EC stiffness in the descending aorta and, thus, may serve as an atheroprotective 
mechanism that maintains endothelial barrier function.
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Introduction:   
Mechanical forces influence nearly all aspects of cell behaviour, including apoptosis, 
transcription and translation, differentiation and cell migration9, 11, 79-81.  The mechanical 
environment of a cell consists of both cell-generated (endogenous) and applied (exogenous) 
forces. Endogenous forces are generated when a cell pulls on its extracellular matrix (ECM) 
or its neighbours via its cytoskeleton. Examples of exogenous forces include the mechanical 
force of shear stress applied on endothelial cells (ECs) due to blood flow, as well as the 
stretching of vascular cells due to blood pressure. It is now well accepted that mechanical 
stresses determine the mechanical properties of cells, which, in turn, influence cell function 
in both physiology and disease. Nevertheless, the relationship between force and biological 
response remains elusive. 
Various methods have been used to apply exogenous forces to cells7, 82, 83.  These 
studies have revealed that when force is applied to mechanosensitive proteins, the cells 
respond by increasing their stiffness. This is a physiological response that is required in 
order to resist the applied force; however, increased stiffness is also associated with 
pathologies such as cardiovascular disease and cancer55, 84, 85.	  	  We and others have 
demonstrated that the stiffening response requires the coordination of numerous signaling 
cascades, including activation of the small GTPase RhoA7, 13, 82.  Effectors downstream of 
the GTPase coordinate changes in the actin cytoskeleton and focal adhesions in an effort 
resist the applied	  force13.  
 While much work has focused on integrin-mediated force transduction, recent work 
has highlighted other mechanosensitive proteins, such as cadherins and PECAM-110-13.  
PECAM-1 is a critical mechanosensor in the endothelium that activates a number of 
intracellular signaling cascades in response to the hemodynamic force of shear stress29.  
We recently reported that ECs adherent on fibronectin (FN) generate an adaptive stiffening 
response when tension is applied to PECAM-113.  Interestingly, this response is dependent 
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on integrin ligation with the underlying ECM.  Integrin heterodimers differ in their ECM 
specificity based on their α/β subunit composition, and therefore bind to distinct extracellular 
matrix proteins.  Several studies have reported matrix-specific signaling through different 
integrin subtypes within the endothelium41, 42, 44.  Throughout most of the vasculature, 
collagen (CL) and laminins are the predominant ECM proteins.  However, distinct regions of 
the vasculature are rich in FN deposition and therefore differ in matrix composition. Thus, 
variances in matrix composition permit activation of ECM-specific signaling cascades in 
localized regions of the vasculature.  For instance, fluid shear stress activates protein kinase 
A (PKA) in ECs adherent on CL, whereas PKA activity is unaffected when ECs adherent on 
FN are exposed to shear stress44.  While ECM-specific signaling cascades have been 
identified, how these divergent signaling pathways affect mechanical signaling and cellular 
function is not known.  Here, we investigate how the ECM identity and signaling through 
discrete integrin subtypes influences the cellular response to tension on PECAM-1. We 
identify that CL-dependent activation of PKA in response to mechanical force on PECAM-1 
negatively regulates RhoA activity.  Furthermore, we show that PKA-mediated inhibition of 
RhoA modulates the EC force response and focal adhesion dynamics in vitro and in vivo to, 
ultimately, dampen EC stiffness in the CL-rich descending aorta.  
 
Results:  
The ECM determines the cellular mechanical response to tension on PECAM-1 
In order to investigate the role of ECM composition on the mechanical response to 
tension on PECAM-1, we utilized magnetic tweezers to apply pulsatile force to ECs 
adherent on FN or CL.  ECs incubated with anti-PECAM-1-coated paramagnetic beads were 
subjected to 2-second pulses of force over a 2-minute time course (Fig. 3.1a).  In ECs 
adherent on FN, application of successive pulses of force on PECAM-1 resulted in a 
significant decrease in bead displacement during latter pulses (Fig. 3.1b).  This observed 
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reduction in bead displacement is indicative of adaptive stiffening and consistent with 
previous work13.  Surprisingly, when ECs adherent on CL were stimulated with the identical 
force regimen, we could not detect a significant change in pulse-to-pulse bead 
displacement, suggesting that the cells do not generate a force response in this context (Fig. 
3.1b).  Interestingly, absolute displacement of anti-PECAM-1 coated beads during the first 
pulse of force was nearly identical on both FN and CL (Supplementary Fig. S3.1).  These 
results suggest that while ECs adherent on FN or CL have similar basal stiffness, they differ 
dramatically in their ability to respond to exogenous force application.   
          Work from our group and others has demonstrated that the adaptive cellular stiffening 
response is mediated, in part, by an increase in focal adhesions that function to resist the 
applied force5, 13.  To this end, we assessed the focal adhesion profile in ECs plated on FN 
and CL before and after force manipulation.  As previously reported, ECs adherent on FN 
exhibited robust focal adhesion growth in response to force on PECAM-1 (Fig. 3.1c).  
Conversely, and in agreement with the magnetic tweezers data, focal adhesion size or 
number did not significantly increase in ECs adherent on CL following force application.  
Taken together, these data indicate that the ECM composition has a profound effect on the 
cellular response to tension on PECAM-1.  ECs adherent on FN generate an adaptive 
stiffening response, accompanied by significant focal adhesion growth, whereas ECs 
adherent on CL do not generate a significant force response or restructure focal adhesions 
in response to tension on PECAM-1. 
 Phosphoinositide 3-kinase (PI3K) is a critical regulator of PECAM-1-mediated 
adaptive stiffening on FN by allowing integrin activation and downstream activation of 
RhoA13.  In order to examine PI3K activation in ECs adherent on CL, anti-PECAM-1-coated 
paramagnetic beads bound to ECs expressing a GFP-PH fusion protein (which serves as a 
sensor for PI3-lipids) were subjected to force using a permanent ceramic magnet.  Brief 
force application induced rapid PI3K activation around anti-PECAM-1-coated beads 
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(Supplementary Fig. S2b) at levels similar to those previously reported in ECs adherent on 
FN13.  These results suggest that the impaired mechanical response on CL is not due to 
insufficient PI3K activation.    In order to assess force-dependent changes in collagen-
binding integrin (α2β1) activity, ECs adherent on CL were subjected to force and 
immunostained with an antibody that recognizes ligated β1 integrins.  ECs exhibited 
transient but robust integrin activation after force application (Supplementary Fig. S3.2b), 
suggesting that the lack of a mechanical response in ECs adherent on CL may be due to 
divergent signaling downstream of CL-binding integrins. 
 
Mechanically-induced PKA activity negatively regulates RhoA  
Activation of the small GTPase RhoA is known to be important for the cellular 
stiffening response7, 13, 82.  Importantly, RhoA activation in response to tension on PECAM-1 
requires integrin activation and ligation with the underlying ECM13. Although cells on CL 
exhibited significant integrin activation in response to tensional force on PECAM-1, we next 
examined if downstream RhoA activation was affected by adhesion to collagen.  Tension on 
PECAM-1 resulted in robust, but transient activation of RhoA, as levels of GTP-bound RhoA 
increased at 5 min of force, but returned to basal levels by 30 min of force (Fig. 2a).  This 
transient response is in striking contrast to the prolonged RhoA activation that occurs when 
tension is applied to ECs adherent on FN (Fig. 2b).   
 Rho GTPases are very tightly regulated in order to allow for proper signaling in 
response to distinct stimuli, and thus, activity is regulated in three ways:  activation (GTP-
loading) by a guanine nucleotide exchange factor (GEF), hydrolysis of GTP via a GTPase 
activating protein (GAP), and inactivation via association with a GDP-dissociation inhibitor 
(GDI)86.  Given the transient nature of force-induced RhoA activation on CL, we 
hypothesized that differential association with GDI might contribute to the decrease in RhoA 
activity.  We considered association with a GDI as an attractive possibility for several 
	  	  
58	  
 
reasons.  Inactivation of RhoA (via association with Rho-GDI) is modulated by serine 
phosphorylation of the GTPase87-89.  PKA has been implicated as a negative regulator of 
RhoA activity via phosphorylation of RhoA serine 18889.  Interestingly, ECs exhibit 
mechanosensitive and matrix-specific activation of PKA, such that the kinase is activated in 
ECs adherent on CL in response to the mechanical stimulus of fluid shear stress but not 
activated in ECs adherent on FN44.  Therefore, we hypothesized that matrix-specific 
activation of PKA negatively regulates RhoA activity on CL and inactivates the GTPase by 
the 30 min time point.  In order to test this hypothesis, levels of RhoA serine phosphorylation 
following force application on PECAM-1 were assessed by immunoprecipitation and 
immunoblot analysis (Fig. 3.2c).  Indeed, ECs exhibited force-induced serine 
phosphorylation in response to tension on PECAM-1, suggesting that RhoA may be 
inactivated via serine phosphorylation at later time points.   We next sought to determine if 
PKA is activated following force application on PECAM-1.  In agreement with our 
hypothesis, we detected a force-dependent increase in PKA phosphorylation in ECs on CL, 
indicating activation of the kinase downstream of PECAM-1 (Fig. 3.2d).  Furthermore, 
mechanical activation of PKA was specific to ECs on CL, as activity of the kinase did not 
change when ECs adherent on FN were subjected to force (Supplementary Fig. S3.3).  In 
order to test if PKA mediates force-induced serine phosphorylation of RhoA, ECs were 
pretreated with the PKA inhibitor PKI, prior to mechanical stimulation of PECAM-1.  
Consistent with our hypothesis, PKA inhibition completely abolished force-dependent RhoA 
phosphorylation (Fig. 3.2e).  Taken together these data suggest that force-induced 
activation of PKA promotes phosphorylation and inactivation of RhoA in ECs adherent on 
CL.  Thus, we reasoned that abrogation of PKA signaling and therefore, inhibition of RhoA 
serine phosphorylation should also influence levels of active or GTP-bound RhoA in 
response to tension on PECAM-1. In agreement with our hypothesis, blockade of PKA 
signaling resulted in robust and sustained activation of RhoA (Fig. 3.2f).  Taken together, 
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these data indicate that PKA activation modulates RhoA serine phosphorylation and, thus, 
activity of the GTPase in response to tension on PECAM-1. 
 
Inhibition of PKA confers mechanical responsiveness to ECs on CL 
 In light of these data, we hypothesized that inhibition of PKA (and prolonged 
activation of RhoA) may confer the stiffening response to ECs adherent on CL. To address 
this, we pretreated ECs with the PKA inhibitor prior to stimulating PECAM-1 in the magnetic 
tweezers system.  Control ECs did not respond to tension on PECAM-1 (similar to Fig. 
3.1a).  In contrast, inhibition of PKA signaling resulted in a rapid and significant adaptive 
stiffening response (Fig. 3.3a).  These data suggest that prolonged activation of RhoA is 
sufficient to restore mechanical responsiveness to tension on PECAM-1.  In order to 
examine if inhibition of PKA permitted force-induced growth of focal adhesions in cells 
attached to CL, ECs pretreated with PKI were subjected to force and immunostained for the 
focal adhesion protein vinculin.  In agreement with our magnetic tweezers studies, blockade 
of PKA signaling resulted in a significant increase in focal adhesion size and number, 
whereas vehicle-treated ECs did not exhibit significant focal adhesion growth (Fig. 3.3b).  
Thus, our data indicate that suppression of PKA signaling restores the mechanical response 
to tension on PECAM-1. 
 
The PKA pathway regulates hemodynamic-induced focal adhesion dynamics in vitro 
and in vivo 
Our data indicates that PKA is responsible for regulating matrix-dependent stiffening 
and focal adhesion growth in response to applied magnetic forces.  However, the 
hemodynamic force of fluid shear stress is the critical physiological force in vivo.  
Furthermore, ECs subjected to shear stress remodel their focal adhesions in order to resist 
shear forces90, 91, and PECAM-1 is part of a mechanosensory complex that influences 
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cytoskeleton dynamics in ECs subjected to fluid shear stress29. Therefore, we extended our 
studies to investigate the role of the PKA pathway in EC focal adhesion dynamics in 
response fluid shear stress. ECs plated on CL were subjected to shear stress (12 dyn/cm2) 
and immunostained for vinculin to highlight focal adhesions (Fig. 3.4a).  ECs subjected to 
shear stress displayed a 2-fold increase in focal adhesion number (Supplementary Fig. 
S3.4a), consistent with previous reports22.  Furthermore, we found that inhibition of PKA 
signaling significantly augmented shear-induced focal adhesion growth (Fig. 3.4a), similar to 
the growth of focal adhesions observed when tension was applied on PECAM-1 (Fig. 3.3b).  
It is important to note that inhibition of PKA did not significantly influence focal adhesion size 
or number in the absence of shear stress (Supplementary Fig. S3.4b).  Thus, these data 
indicate that PKA regulates focal adhesion dynamics in response to the physiological 
stimulus of fluid shear stress. 
 We sought to extend our in vitro shear stress studies to an in vivo setting. We 
examined focal adhesions in the descending aorta, as it is rich in collagen composition and 
experiences relatively uniform shear stress patterns.  In order to test if PKA regulates focal 
adhesion growth in vivo, wildtype mice were injected with PKA inhibitor (PKI) or vehicle 
(DMSO).  Two hours after injection, the descending aorta was harvested and en face 
preparations were immunostained with vinculin to highlight focal adhesions in the 
endothelium.  Remarkably, inhibition of PKA signaling in vivo resulted in a significant 
increase in the number of focal adhesions present in the descending aorta (Fig. 3.4b) 
compared to control, suggesting that the PKA pathway is also a critical regulator of focal 
adhesion dynamics in ECs in the hemodynamic environment of the vessel.  
 
The PKA pathway modulates hemodynamic-induced aortic endothelial cell stiffness 
Several studies have suggested a link between vessel stiffness and cardiovascular 
disease55, 84, 85.  However, measurements of EC stiffness ex vivo are lacking and the 
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mechanisms that govern aortic EC stiffness remain largely unexplored. Our in vitro data 
suggest that growth of focal adhesions corresponds with a stiffer EC phenotype and that 
activation of the PKA pathway exerts a negative effect on active stiffening responses via 
inhibition of RhoA signaling. In contrast, suppression of PKA signaling restores 
mechanotransduction in response to tension on PECAM-1 (Fig. 3.3b), shear stress 
application in vitro (Fig. 4a), and in the hemodynamic environment of the blood vessel (Fig. 
3.4b). In order to test the direct physiological relevance of these effects, we used external 
passive microbead rheology92 to determine whether the PKA pathway is also a determinant 
of EC stiffness in vivo.  The descending aorta was freshly isolated from control or PKI-
treated mice two hours after injection and prepared en face to expose the endothelium for 
passive microbead rheology measurements.  The descending aorta was incubated with FN-
conjugated beads in order to establish integrin-mediated attachments with the cortical actin 
cytoskeleton.   Thermal motion of attached beads was tracked and the resulting mean-
squared displacements (MSD) were calculated for control or PKI-treated aortas (Fig. 3.5a).  
Of note, MSD trajectories show a slope less than unity (illustrated by black guide line in Fig 
3.5b), indicating a sub-diffusive viscoelastic response consistent with the movements of 
beads anchored to the actin cytoskeleton via integrins93.   Ensemble-averaging of the bead 
populations revealed a significant decrease in MSD magnitude in PKI-treated aortas 
compared to control aortas (Fig. 3.5b). Furthermore, calculation of the average root mean-
squared (RMS) at the 1-second timescale for each condition revealed a significant decrease 
in the effective radius of bead displacement in PKI-treated aortas (Fig. 3.5c).  These data 
suggest a significant increase in stiffness in the endothelium of PKI-treated aortas compared 
to control aortas.  Thus, the PKA pathway appears to be a significant regulator of EC 
stiffness in the CL-rich descending aorta. 
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Discussion:  
Here we identify a novel pathway that regulates endothelial mechanical responses 
and determines aortic EC stiffness, which may contribute to maintenance of blood vessel 
integrity. We sought out to determine the role of ECM identity in PECAM-1-mediated 
mechanotransduction and discovered that while some responses are common, ECs 
adherent on CL display divergent signaling in response to mechanical tension on PECAM-1 
compared to ECs adherent on FN. Although tension on PECAM-1 induces PI3K and 
downstream integrin activation, ECs on do not generate a stiffening response, which may be 
partially attributed to reduced focal adhesion remodeling.  Mechanistically, we demonstrate 
that mechanical tension on PECAM-1 results in activation of RhoA in cells adherent on CL, 
which is rapidly deactivated by PKA-dependent Ser188 phosphorylation of RhoA.  Inhibition 
of PKA signaling prolongs force-induced RhoA activation and results in cellular stiffening 
and focal adhesion growth in response to force (Fig. 3.6).  We further extended these 
findings to the physiological hemodynamic stimulus of fluid shear stress and reveal that PKA 
negatively regulates focal adhesion dynamics in ECs in vitro and in the hemodynamic 
environment of the vessel in vivo.   Finally, we highlight PKA as a critical regulator of EC 
mechanics and demonstrate active regulation of aortic EC stiffness in vivo.  
PKA is a multifunctional protein that has many roles in cell biology.  Within the 
endothelium, the kinase has well documented roles in anti-inflammatory signaling15, 
angiogenesis94, barrier function95, 96, and cell migration97.  Importantly, PKA-mediated RhoA 
inactivation has been shown to regulate endothelial barrier function in vitro95, and the kinase 
has been shown to tightly regulate RhoA activity during protrusion-retraction cycles in 
migrating cells87, 97.  Here, we demonstrate that PKA inhibition of RhoA signaling also 
influences EC responsiveness to force and focal adhesion dynamics.  PKA can directly 
phosphorylate RhoA at serine 188, and phosphorylation of this residue inhibits activity of the 
GTPase87, 89.  Serine phosphorylation of RhoA increases its association with Rho-GDI and 
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negatively influences activity by sequestering the GTPase in the cytoplasm88. In addition to 
its role regulating RhoA activity, a complex relationship between PKA and integrin-mediated 
adhesion also exists.  Detachment of cells from the ECM triggers robust, but transient, 
activation of the kinase98, 99.  Conversely, integrin-mediated adhesion also stimulates PKA 
activation and is important for strengthening cell-cell and cell-matrix adhesions in certain cell 
types100.  For instance, G-protein-coupled receptor-mediated activation of PKA promotes 
cell-cell adhesion and inhibits cell migration in a Csk-dependent manner94.   
Our work highlights RhoA as a critical mediator the cellular response to force.  While 
mechanical stimulation of PECAM-1 induces RhoA activation in ECs adherent on CL, 
activation is transient and insufficient to initiate adaptive stiffening and focal adhesion 
growth.  While we provide evidence for RhoA inactivation via serine phosphorylation, it is 
possible that force-dependent changes in GEF and GAP activity may also contribute to 
transient activation of the GTPase.  For instance, p190RhoGAP is rapidly phosphorylated in 
ECs exposed to shear stress, and the GAP is required for flow-mediated changes in the 
actin cytoskeleton101.  Therefore, it is possible that force-dependent activation of 
p190RhoGAP may also influence RhoA activity.  In addition, previous work from our lab 
identified activation of GEF-H1 in response to tension on PECAM-113.  Interestingly, others 
have shown that PKA-dependent phosphorylation of GEF-H1 suppresses its GEF activity102.  
Therefore, it is also possible that force-dependent PKA activation inhibits GEF-H1-mediated 
GTP-loading at later time points.  Nevertheless, our results clearly indicate that PKA 
regulates RhoA activity and the cellular response to mechanical force.  
Our in vivo studies suggest that PKA signaling in the descending aorta inhibits focal 
adhesion growth and promotes a compliant cellular phenotype.  The descending aorta is 
rich in CL composition and, notably, more resistant to atherosclerotic plaque development 
compared to other regions of the vasculature. Our data indicate that focal adhesion growth 
corresponds to a stiffer EC phenotype and that the presence of CL suppresses this 
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phenotype.  Interestingly, focal adhesions in other vascular cell types in the vessel have 
been identified as major contributors to aortic stiffness103, and our rheology studies suggest 
that growth of focal adhesions may also contribute to aortic EC stiffness. Interestingly, 
vessel stiffness positively correlates with EC permeability and leukocyte transmigration55, 
and thus, contributes to the development of vascular disease.  Therefore, PKA-mediated 
suppression of RhoA activity and inhibition of focal adhesion growth in the descending aorta 
may serve as a protective mechanism that maintains endothelial barrier function and 
regulates permeability. 
Overall, our work identifies a unique mechanosensitive and ECM-dependent 
signaling pathway that regulates EC stiffness and focal adhesion dynamics.  Using magnetic 
tweezers, we show that tension on PECAM-1 initiates an intracellular signaling cascade that 
regulates the cellular force response and focal adhesion growth. We further demonstrate 
that PECAM-1-dependent PKA signaling influences focal adhesion dynamics and EC 
stiffness in vitro and in vivo and may function as an atheroprotective mechanism in distinct 
regions of the vasculature. 
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Figures 
Figure 3.1   ECM composition influences the cellular response to tension on PECAM-1 
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(a) Pulsatile force regimen applied with magnetic tweezers, consisting of a 2 second, 100-
pN pulse of force, followed by a 10 second period of rest, repeated over a 2 minute time 
course. (b) Average relative anti-PECAM-1-coated bead displacements induced by pulsatile 
force regimen.  ECs were seeded on FN or CL 4 hrs prior to incubation with magnetic 
beads.  Average displacements were calculated relative to the first pulse of force. (n >30 
beads/condition from 3 independent experiments).  Error bars represent s.e.m., *p<0.05.  (c) 
Adherent ECs on FN or CL were incubated with anti-PECAM-1-coated magnetic beads and 
subjected to force with a permanent magnet for the indicated times.  ECs were fixed stained 
with phalloidin and an anti-vinculin antibody to mark focal adhesions. Focal adhesion 
number and size were quantified using NIH ImageJ software.  Values were normalized to 
the FN “No Force” condition.  Locations of the beads are highlighted in yellow circles (n > 
30cells/condition from 3 independent experiments, *p < 0.05, scale bar = 10µm). 
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Figure 3.2 Mechanically-induced PKA activity negatively regulates RhoA. 
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(a-e) Tension was applied to anti-PECAM-1-coated beads using a permanent ceramic 
magnet for the indicated times, and (a) Active RhoA (RhoA-GTP) was isolated from EC 
adherent on CL with GST-RBD and analyzed by western blot (n=5). (b) Active RhoA (RhoA-
GTP) was isolated from EC adherent on FN with GST-RBD and analyzed by western blot 
(n=5). (c) Total RhoA protein was immunoprecipitated from cell lysates and immune 
complexes were subjected to SDS-PAGE, followed by immunoblotting with phosphoserine 
and RhoA antibodies (n=3).  (d) Cell lysates were subjected to SDS-PAGE and 
immunoblotted for phospho (Tyr497) and total PKA (n=3).  (e-f)  ECs were treated with PKI 
(20uM for 1hr) or DMSO and tension was applied to anti-PECAM-1-coated beads using a 
permanent ceramic magnet for the indicated times. (e) Total RhoA protein was 
immunoprecipitated from cell lysates and immune complexes were subjected to SDS-PAGE, 
followed by immunoblotting with phosphoserine and RhoA antibodies (n=3).  (f) Active RhoA 
(RhoA-GTP) was isolated with GST-RBD and analyzed by western blot (n=3).  Bar graphs 
display averages from at least three independent experiments and error bars indicate s.e.m, 
*p<0.05.  
	  	  
69	  
 
Figure 3.3 Inhibition of PKA confers mechanical responsiveness to ECs on CL.   
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(a-b) ECs were pretreated with PKI (20uM) or vehicle for 1 hr, and (a) Pulsatile forces were 
applied to PECAM-1 with magnetic tweezers. Average relative anti-PECAM-1-coated bead 
displacements induced by pulsatile force regimen.    Average displacements were calculated 
relative to the first pulse of force. (n >20 beads/condition from 3 independent experiments).  
(b) Anti-PECAM-1-coated magnetic beads were subjected to force with a permanent 
ceramic magnet for the indicated times.  ECs were fixed stained with phalloidin and an anti-
vinculin antibody to mark focal adhesions. Focal adhesion number and size were quantified 
using NIH ImageJ software.  Values were normalized to the DMSO “No Force” condition.  
Locations of the beads are highlighted in yellow circles (n > 30cells/condition from 3 
independent experiments, *p < 0.05, scale bar = 10µm). 
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Figure 3.4  The PKA pathway regulates hemodynamic -induced focal adhesion 
dynamics in vitro and in vivo. 
 
(a)  ECs adherent on CL pretreated with PKI (20uM, 1 hr) or vehicle and subjected to shear 
stress (12 dyn/cm2 for 30min).  Cells were fixed and immunostained with anti-vinculin and 
anti-β-catenin antibodies. Focal adhesion number and size were quantified using NIH 
ImageJ software.  Values were normalized to the vehicle condition (n=3).  (b)  Vehicle or PKI 
Vehicle 
PKI 
Vinculin β-catenin Merge 
0 
0.4 
0.8 
1.2 
1.6 
N
or
m
al
iz
ed
 F
A 
si
ze
 
*
*
FA Size 
FA Number 
a. 
Vehicle 
PKI 
*"
Vinculin VE-cadherin Merge 
FA Number 
b. 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
N
or
m
al
iz
ed
 F
A 
# 
Vehicle 
PKI 
0 
0.4 
0.8 
1.2 
1.6 
2 
2.4 
N
or
m
al
iz
ed
 F
A 
# Vehicle 
PKI 
	  	  
72	  
 
(5nmol) was administered to wildtype mice by retro-orbital injection.  Two hrs after injection, 
aortas were harvested and en face preparations were immunostained with anti-vinculin and 
anti-VE-cadherin antibodies.  Focal adhesions were quantified using NIH ImageJ software.  
Values were normalized to the vehicle (condition for each genotype (n=4 mice/group).
	  	  
73	  
 
Figure 3.5 The PKA pathway modulates hemodynamic-induced aortic EC stiffness. 
 
 
(a) Vehicle or PKI (5nmol) was administered to wildtype mice by retro-orbital injection.  Two 
hrs after injection, aortas were harvested and en face preparations were incubated with FN-
conjugated beads for external passive microbead rheology.  Mean-squared displacement 
(MSD) trajectories of FN-conjugated, 4.5 µm beads attached to the endothelium of vehicle 
(blue) or PKI-treated (red) mice.  MSDs of individual curves (n > 350 per condition, 
aggregated from three separate mice for each treatment) are shown in light color and the 
ensemble-average is represented by the dark curve with s.e.m. shown for indicated 
timescales.  (b)  Ensemble-averaged MSDs of beads attached to endothelium of vehicle and 
PKI-treated mice.  Curves show a slope less than unity (illustrated by black guide line), 
a.  
PKI Vehicle 
0 
20 
40 
60 
80 
100 
120 
DMSO PKI 
R
M
S 
di
sp
la
ce
m
en
t (
nm
) 
b. c. 
* 
Vehicle 
PKI 
Vehicle
	  	  
74	  
 
indicating a sub-diffusive viscoelastic response of beads anchored to the cortical actin 
cytoskeleton through apical integrin receptors.  (c)  Root mean-squared (RMS) displacement 
at the 1-second timescale (τ = 1 s) of beads attached to endothelium of vehicle and PKI-
treated mice (p < 0.0001). 
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Figure 3.6 Model of collagen-dependent PECAM-1 mechanosignaling. 
 
 
PECAM-1 mechanosignaling through CL-binding integrins results in activation of PKA and 
subsequent phosphorylation and inactivation of RhoA, which blunts EC responsiveness to 
force.  Inhibition of force-induced PKA activation promotes RhoA activation and is sufficient 
to restore the cellular response to force, including growth of focal adhesion and increased 
cellular stiffness.
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Experimental Procedures 
Cell culture and shear stress.  Bovine aortic endothelial cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM, Cellgro) with 10% fetal bovine serum and 1% 
penicillin/streptomycin solution.  Cells were plated on fibronectin (10µg/ml) or Type I 
collagen (40µg/ml) 4 hours prior to experiments. For shear stress experiments, endothelial 
cells were plated on 40 µg/ml collagen in 0.5% FBS.  Four hours after plating, cells were 
slides were loaded onto a parallel plate flow chamber in 0.5% FBS and 12 dynes/cm2 of 
shear stress was applied for indicated times. 
 
Reagents, inhibitors, and antibodies.  PKI was purchased from Calbiochem.  The 
PECAM-1 antibody (PECAM 1.3) was a generous gift from D.K. Newman (BloodCenter of 
Wisconsin).  The RhoA antibody (26C4) was purchased from Santa Cruz Biotechnologies.  
The phospho-PKA and total PKA antibodies were from Cell Signaling, and the phospho-
serine antibody and rhodamine-phalloidin were from Invitrogen.  The vinculin and β-catenin 
antibodies were obtained from Sigma and the HUTS-4 antibody (which recognizes ligated 
β1 integrin) was purchased from Millipore.  The VE-cadherin antibody was from B.D. 
Pharminogen.   
 
Preparation of beads.  Tosyl-activated paramagnetic beads (2.8 or 4.5um, Invitrogen) were 
washed with PBS and coated with an anti-PECAM-1 antibody (PECAM 1.3) or purified 
human fibronectin according to the manufacturer’s protocol.  Beads were quenched in 0.2M 
Tris prior to use to remove any remaining tosyl groups and were resuspended in PBS or 
DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin solution.  
Immediately before experiments, ECs were incubated with beads (2-6 bead/cell) for 30min 
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at 37ºC.  Cells were briefly washed with fresh media to remove unbound beads prior to force 
application.  
 
Pulsatile force application.  The UNC 3D Force Microscope (3DFM) was used to apply 
controlled pulsatile forces (~100pN) to anti-PECAM-1-coated magnetic beads (2.8µm 
diameter).  Bead displacements were recorded with a high-speed video camera (Pulnix, JAI) 
and tracked using Video Spot Tracker (Computer Integrated Systems for Microscopy and 
Manipulation, http://cismm.cs.unc.edu/).  
 
Permanent force application.  For all immunostaining and biochemical analyses, 
continuous force (~10pN) was applied to anti-PECAM-1-coated beads (4.5µm diameter) 
using a permanent ceramic magnet (K&J Magnetics) parallel to the cell culture dish at a 
distance of 1cm from the adherent cells.  
 
Immunofluorescence.  ECs subjected to force (permanent magnet, 4.5µm beads) were 
fixed for 20min in PBS containing 2% formaldehyde, permeabilized with 0.2% Triton X-100, 
and blocked with PBS containing 10% goat serum for 1hr at room temperature.  Antibody 
incubations were performed as previously described13 and mounted in Vectashield mounting 
medium.  Images were acquired using a confocal microscope (Olympus FV500) with a 63x 
oil lens. 
 
Rho Pulldowns.  Adherent cells were incubated with anti-PECAM-1-coated beads (4.5µm, 
Invitrogen) for 30min and subjected to force for indicated times. Briefly, following force 
application, cells were lysed in 50mM Tris (pH7.6), 500mM NaCl, 1% Triton X-100, 0.1% 
SDS, 0.5% deoxycholate, 10mM MgCl2, and protease inhibitors.  Anti-PECAM-1-coated 
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magnetic beads were removed from lysates with a magnetic separator.  Lysates were 
centrifuged for 5min and supernatants were transferred to a new tube and incubated at 4°° 
with 80µg of purified (GST-RBD) bound to glutathione-sepharose beads.  Bead pellets were 
washed in 50mM Tris (pH 7.6), 150mM NaCl, 1% Triton X-100, 10mM MgCl2, and protease 
inhibitors, and subsequently resuspended in Laemmli sample buffer and subjected to SDS-
PAGE. 
 
Immunoprecipitation and western blotting.  Cells were harvested in lysis buffer (20mM 
Tris (pH 7.4), 150mM NaCl, 50mM NaF, 1% NP-40) supplemented with 10 µg/ml aprotinin, 
10 µg/ml leupeptin, 1 mM PMSF, 1 mM Na3VO4, 1 mM sodium pyrophosphate, and 1 mM β-
glycerophosphate.  Lysates were pre-cleared with 15µl protein A/G plus sepharose beads 
(Santa Cruz) for 1 h at 4°C.  Supernatants were then incubated with 30µl protein A/G plus 
sepharose previously coupled to the primary antibodies for 3 h at 4°C with continuous 
agitation.  The beads were washed three times with lysis buffer supplemented with protease 
and phosphatase inhibitors and the immune complexes were eluted in 2X SDS sample 
buffer.  Associated proteins were subjected to SDS-PAGE and Western blotting using the 
appropriate primary antibodies and IRDye-conjugated anti-mouse or anti-rabbit antibodies 
(Rockland).  Images of Western blotting were obtained with an Odyssey infrared scanner 
system. 
 
Quantification of integrin activation and focal adhesions.  ECs stained for ligated β1 
integrin (Fig. S2B) or vinculin were analyzed with NIH ImageJ software.  Confocal image 
planes at the basal surface of the cell were chosen for analysis and RGB images were 
converted to 8-bit black and white images.  Activated integrins and focal adhesions were 
defined by setting an intensity threshold to remove any background signal.  Integrin 
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activation and focal adhesion size and number were analyzed using the ‘Analyze particles’ 
function. 
 
Animals and en face aorta preparations. 5nmol of PKI or DMSO was administered by 
retro-orbital injection into 10-12 wk old wildtype.  Two hrs after injection, descending aortas 
were isolated and processed for en face immunostaining.   Briefly, the aorta was perfusion-
fixed and dissected out under dissection microscope. The descending aortas were cut 
longitudinally and pinned flat with endothelium facing up onto a Surperfrost/Plus glass slide 
(Fisher Scientific).  Tissue sections were stained with anti-vinculin or anti-vinculin antibodies 
an imaged as described above. 
 
Passive microbead assay for mechanical analysis of aortic endothelium. 
The aorta was freshly isolated and prepared en face on a coverslip.  Briefly, the heart was 
perfused with PBS containing heparin and nitroprusside and the live aorta was dissected out 
under a dissection microscope, cut longitudinally, and mounted on a glass coverslip with the 
endothelium facing up.  To anchor the aorta to the coverslip for experiments, a thin sheet 
(roughly 20 x 40 x 2 mm) of polydimethylsiloxane rubber (PDMS) (Sylgard 184, Dow 
Corning) was positioned over the tissue.  A small section (3 x 5 mm) of the PDMS sheet was 
removed previous to anchorage to serve as a media reservoir over the descending 
endothelium (Supplementary Figure S4).  The reservoir was immediately filled with Medium 
199 containing 10% FBS and 15mM HEPES in order to keep the tissue alive.  Fibronectin-
conjugated paramagnetic beads (4.5µm, Invitrogen) were incubated over the endothelium 
for 20 minutes at 37°C.  The thermal motion of attached beads was imaged at 40X using an 
upright reflective microscope (Orthoplan, Leitz) and recorded at 30 frames per second with a 
high-speed video camera (Pulnix, JAI).  Bead motion was monitored for 1 minute and 
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tracked using Video Spot Tracker software (Computer Integrated Systems for Microscopy 
and Manipulation, http://cismm.cs.unc.edu/).  The time-dependent mean-squared 
displacement (MSD) of the bead trajectories was computed using <r2 (τ)> = <MSD> = 
<[x(t+τ)- x(t)]2 + [y(t+τ)- y(t)]2>, where t is the elapsed time and τ is the time lag, or timescale.  
Beads included into analysis were separated from other beads by 3 bead-diameters.  
Conditions were compared using the ensemble-averaged MSD and the root mean-squared 
(RMS) displacement. 
 
Statistical analysis.  Data are presented as means +/- S.E.M.  p-values were determined 
using a two-tailed unpaired Student’s t-test. 
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Supplemental Figures 
 
Supplementary Figure S3.1  ECM identity does not influence 1st pulse bead 
displacement.   
 
 
 
 
 
 
 
 
ECs adherent on FN or CL were incubated with anti-PECAM-1-coated beads and subjected 
to pulsatile force.  Bead displacement during the first pulse of force was calculate for each 
condition.  Error bars represent s.e.m., n>15 cells/condition, and p < 0.05. 
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Supplementary Figure S3.2  Force-induced PI3K and integrin activation.   
 
 
(A)  ECs expressing GFP-PH were incubated with anti-PECAM-1-coated magnetic beads 
and subjected to force with a permanent ceramic magnet for the indicated times.  Cells were 
fixed and scored for GFP-PH recruitment around the bead (box).  Location of the bead is 
highlighted by the yellow circle (n>30 cell/condition for three independent experiments; scale 
bare = 10µm, p < 0.05).  (B)  ECs were incubated with anti-PECAM-1-coated beads and 
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subjected to force with a permanent ceramic magnet for the indicated times.  ECs were fixed 
and stained with HUTS-4, which recognizes ligated β1 integrin, and phalloidin to mark the 
actin cytoskeleton.  (n>30 cells/condition from three independent experiments; scare bar = 
10µm, p < 0.05). 
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Supplementary Figure 3.3 PKA is not mechanically activated in ECs adherent on FN 
 
 
 
Tension was applied to anti-PECAM-1-coated beads attached to cells adherent on FN using 
a permanent ceramic magnet for the indicated times. Cell lysates were subjected to SDS-
PAGE and immunoblotted for phospho (Tyr497) and total PKA (n=3).  Bar graph displays 
the average fold change in pPKA from at least three independent experiments and error 
bars indicate s.e.m. 
 
	  	  
85	  
 
 Supplementary Figure S3.4    Regulation of EC focal adhesion profile. 
 
(a)  ECs adherent on CL were subjected to shear stress (12 dyn/cm2 for 30min) or left as 
static controls.  Cells were fixed and immunostained with anti-vinculin and anti-β-catenin 
antibodies. Focal adhesion number and size were quantified using NIH ImageJ software.  
Values were normalized to the static condition (n=3).   (b) ECs adherent on CL treated with 
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PKI (20uM, 1 hr) or DMSO. Cells were fixed and immunostained with anti-vinculin and anti-
β-catenin antibodies. Focal adhesion number and size were quantified using NIH ImageJ 
software.  Values were normalized to the control (DMSO) condition (n=3).  Bar graphs 
display the averages from three independent experiments and error bars indicate s.e.m., 
p<0.05. 
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CHAPTER IV.   
CONCLUSIONS AND PERSPECTIVES. 
 
 
OVERVIEW 
 In Chapters II and III of this dissertation, I have highlighted several new findings that 
contribute to our understanding of both cell biology and vascular biology. In response to 
recent evidence highlighting the role of mechanical force in numerous biological processes, 
there has been a push towards understanding mechanisms of mechanotransduction in 
recent years.  Forces play a pivotal role in vascular biology, as the hemodynamic force of 
fluid shear stress influences both vessel physiology and pathology.  Thus, there is a need to 
understand how mechanical forces are sensed by ECs and how they are transduced into 
biochemical signaling pathways that will, ultimately, regulate the EC phenotype and 
influence vessel health and integrity.  The work in Chapter II identified molecular signaling 
cascades and cellular phenotypes initiated in response to force on the endothelial 
mechanosensor PECAM-1.  The work in Chapter III identified how cells integrate 
mechanical and extracellular matrix cues to regulate cellular force responses.  This work 
was further extended to the physiological context of shear stress and gave insight into how 
hemodynamic and extracellular matrix cues influence aortic endothelial stiffness, a critical 
determinant of vessel integrity. 
 While Chapters II an III provided novel insights, the research also opened up several 
new questions.  In this Chapter, I will address outstanding questions raised by the research 
presented in this dissertation and discuss how this work contributes to our understanding of 
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how complex mechanical and ECM environments regulate EC responses and vessel health 
in vivo. 
 
 
CHAPTER II:  LOCALIZED TENSIONAL FORCES ON PECAM-1 ELICIT A GLOBAL 
MECHANOTRANSDUCTION RESPONSE VIA THE INTEGRIN-RHOA PATHWAY  
 
In Chapter II, I set out to identify how ECs respond to mechanical force on the 
mechanosensor PECAM-1. Using a magnetic tweezers system, I showed that ECs respond 
to force application on PECAM-1 by employing an adaptive stiffening response.  This work 
also identified two interesting findings: 1) a subset of PECAM-1 mechanosignaling is 
integrin-dependent and therefore, several common mechanotransduction responses 
between PECAM-1 and integrins exist; 2) localized tension on PECAM-1 elicits a global 
mechanotransduction response.  These intriguing findings are discussed in further detail 
below. 
 
Common mechanotransduction responses. 
A number of experimental approaches used to apply tension on integrins, including 
optical or magnetic tweezers and electromagnetic microneedles, have shown that cells can 
sense the applied tension and respond by strengthening their cytoskeletal linkages to 
oppose the force3, 7, 60, 82, 104. Application of tensional forces on anti-PECAM-1-coated beads 
bound to ECs induces a stiffening response that also depends on the actin cytoskeleton, 
similar to integrins.      
In addition to adaptive stiffening, several other mechanosensitive responses are also 
shared between PECAM-1 and integrins.  Force application to either adhesion receptor 
results in RhoA activation through two GEFs, GEF-H1 and LARG, via a FAK/ERK signaling 
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pathway13, 82. Interestingly, RhoA activation in response to tensional force on PECAM-1 is 
integrin dependent, because inhibition of new integrin-ECM connections quenched force-
induced RhoA activity13. This integrin-dependent RhoA activation might explain the shared 
GEFs in both systems. Importantly, RhoA-mediated signaling is required for adaptive 
stiffening downstream of both integrins and PECAM-1, as inhibition of RhoA, its GEFs, or its 
effectors abolishes the force-dependent stiffening response.   Finally, tension on either 
integrins or PECAM-1 also results in growth of focal adhesions, which mechanically couple 
the internal actin cytoskeleton to the extracellular matrix5, 13.  Indeed, the best-defined 
response of integrin-dependent adhesions to tension is reinforcement of the focal adhesions 
to counteract the exogenously applied force, as growth of adhesions increases cell 
generated tension105. Similarly, force on PECAM-1 results in growth of focal adhesions.  In 
contrast to the local adhesion growth observed in response to tension on integrins, PECAM-
1-mediated adhesion growth is a global phenomenon. This leads us to the important 
differences in mechanotransduction cascades between these two cell adhesion molecules 
that will be discussed below. 
 
Differences in mechanotransduction pathways. 
Several differences exist when comparing the cellular response to force application 
on integrins vs. PECAM-1.  Closer examination of some of the shared responses, such as 
adaptive stiffening or RhoA activation, also reveal some notable differences in the cellular 
responses downstream of each receptor.  While mechanical stimulation of either adhesion 
receptor results in adaptive stiffening, the time course of the response varies between the 
two proteins.  Tension applied to FN-binding integrins results in an immediate stiffening 
response, as differences in cellular stiffness can be detected immediately following force 
application.  Conversely, while force application on PECAM-1 also elicits adaptive stiffening, 
the response is delayed and is detectable on a minute, rather than second timescale.  This 
	  	  
90	  
 
same trend is also observed when taking a closer look at the time course of RhoA 
activation.  Force application on integrins results in an increase in RhoA activity in as little as 
1 min.  In contrast, force-induced RhoA activation downstream of PECAM-1 does not 
increase until 5 min of force.  Therefore, it is possible that the delay in the PECAM-1-
mediated adaptive stiffening response is a reflection of delayed RhoA activation.  
Differences in the time course of these events may be attributed to differences in 
mechanisms of signal transduction.  Mechanosensitive signaling pathways may be 
chemically or mechanically propagated throughout the cell, via diffusion of small chemical 
messengers or mechanically transmitted through cytoskeletal filaments, respectively.  
Indeed, mechanical signals can be propagated at a remarkable speed of 30 m/s, whereas 
biochemical signals diffuse at a mere rate of 2 µm/s 6.  Given integrins’ intimate association 
with the cytoskeleton, it is possible that integrin-mediated mechanotransduction relies more 
heavily on mechanical transmission of the signaling cascade, while PECAM-1-mediated 
mechanotransduction is more chemically dependent in nature.   
 Perhaps the most profound difference between integrin and PECAM-1-mediated 
mechanosignaling involves the spatial organization of the response.  Several studies have 
revealed that integrin-mediated adaptive stiffening response is mediated, in part, by 
localized recruitment of focal adhesion proteins (such as β1 and β3 integrins, talin, and 
vinculin), which results in a local growth of adhesions at the site of force application5, 8.  
Similarly, force application on integrins induces localized recruitment of LARG and GEF-H1 
to the adhesion complex4. Furthermore, mRNA and ribosomes also specifically localize to 
focal adhesions that form when cells bind to FN-coated microbeads9. Surprisingly, our work 
has revealed that tension on PECAM-1 results in a remarkable cell-wide, or global, 
mechanotransduction response, as evidenced by a cell-wide increase in focal adhesion 
growth.  This result is especially intriguing, as it is the first documented evidence of a global 
mechanotransduction event elicited by a localized force.  While studies from Ning Wang’s 
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group have reported Src and Rac activation at remote sites away from stress application 
with RGD-coated beads6, 68, 106, neither signal displayed cell-wide distribution. Nevertheless, 
it has been shown that global, cell-wide changes in cytoskeletal structure and mechanics 
can regulate mechanotransduction, such that the mechanotransduction response is 
governed by global mechanical cues, including isometric tension (pre-stress) within the 
cytoskeleton106, 107.  
 
Globalization of Mechanotransduction. 
How does a localized force on PECAM-1 elicit a global response?  
Phosphoinositide 3-kinase (PI3K) is rapidly activated following application of tension on 
PECAM-1.  Activation of PI3K results in the production of freely diffusible 
phosphoinositides (such as PI(3,4,5)P3) that act as second messengers to propagate 
signaling cascades throughout the cell.  Experimental evidence suggests that: 1) 
activation of PI3K, and 2) diffusion of the second messenger PI(3,4,5)P3 is required for 
the global response downstream of PECAM-1.  Localized tension on PECAM-1 not only 
elicits global focal adhesion formation, but also results in global integrin and RhoA 
activation.    Interestingly, inhibition of PI3K activation, or sequestration of the PI(3,4,5)P3 
messenger abolishes the global signaling response.  PI3K has been implicated in integrin 
activation in various contexts and cell types, although the exact mechanism of activation 
remains elusive108.  PI(3,4,5)P3 has a documented half-life 60 seconds109 and a fairly 
rapid diffusion rate of 0.1-1 µm/s2 110.  Given that ECs are relatively thin cells (generally 
less that 5µm in height), it is feasible that freely diffusing PI(3,4,5)P3 would be able to 
globally activate integrins at cellular sites distal to the site of force application.  Therefore, 
the current model of PECAM-1-mediated mechanotransduction suggests that PI3K is 
rapidly activated downstream of PECAM-1, and PI(3,4,5)P3 promotes global integrin 
activation. Integrin activation is followed by new binding to the ECM and enlargement of 
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adhesions. Cell-wide activation of integrins elicits global activation of RhoA via the GEF-
H1 and LARG pathway.  This is a crucial aspect of the PECAM-1-mediated response, as 
global activation of the GTPase facilitates global growth of focal adhesions, which 
contribute to the adaptive stiffening response.  This model also highlights cooperation of 
two mechanosensors in this system:  PECAM-1 and integrins.  Not only does PECAM-1 
lead to activation of integrins, but integrin ligation with the ECM is required for force-
induced RhoA activation and adaptive stiffening. 
The requirement of PI3K activation and PI(3,4,5)P3 implies that chemical signaling 
is critical for the global nature of the PECAM-1-mediated response.  However, it remains 
unclear if mechanical propagation of the signal is also required for the global response.  
Transmission of force through tensile cytoskeletal elements can propagate 
mechanosensitive signaling away from sites of applied stress.  For instance, previous 
studies probing integrins reported rapid activation of Src and Rac at remote cytoplasmic 
locations away from the site of mechanical stress 6, 68, 69.  However, these signals were 
not global in nature, but rather were confined to distinct puncta that corresponded with 
sites of cytoskeletal deformation.  It is also important to note that the integrins’ physical 
association with the cytoskeleton has been well documented. Therefore, it is plausible 
that tensile cytoskeletal filaments anchored to integrins on opposing sides of the cell 
could facilitate transmission of a mechanical stimulus across the cell.  However, PECAM-
1 has not been shown to directly interact with the cytoskeleton, although indirect 
association via cytoplasmic interactions with β-catenin and γ-catenin have been proposed 
70.  Furthermore, the exact of mechanism of PECAM-1-mediated mechanosensing 
remains unknown.  Models of mechanotransduction often involve force-dependent 
conformational changes in proteins that permit propagation of mechanosensitive 
signaling cascades.  For instance, α5β1 integrin undergoes a force-dependent 
conformational change111, which allows chemical crosslinking to FN and recruitment and 
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activation FAK.  While it is appealing to hypothesize that PECAM-1-mediated 
mechanotransduction may be dependent on a conformational change, a force-dependent 
change in the protein structure has not yet been identified, and thus, the mechanism of 
mechanosensing remains elusive.  Comprehensive studies investigating the structure of 
the PECAM-1 cytoplasmic tail may provide insights into the mechanisms of PECAM-1-
mediated mechanosignaling and reveal the relative contributions of chemical signaling 
and mechanical transmission in the global mechanotransduction response. 
 
 
CHAPTER III:  HEMODYNAMIC AND EXTRACELLULAR MATRIX CUES REGULATE 
THE MECHANICAL PHENOTYPE AND STIFFNESS OF ENDOTHELIAL CELLS 
 
 In Chapter III, I set out to investigate how ECs integrate mechanical and ECM-
specific cues.  Through my research, I found that the ECM composition has a profound 
effect on the cellular response to tension on PECAM-1.  I demonstrated that matrix-specific 
PKA activation and subsequent de-activation of RhoA influences EC response to force.  I 
further extended these studies to the physiological stimulus of shear stress and the complex 
hemodynamic environment of the vessel.  In this Chapter, I elaborate on our knowledge of 
matrix specific signaling in the endothelium and discuss PKA as a critical regulator of 
endothelial and cardiovascular biology. 
 
Matrix-specific responses to force. 
 Matrix-specific signaling in the endothelium has been well documented in recent 
years.  Fluid shear stress elicits integrin activation and ligation with the underlying ECM43.  
Therefore, activation of divergent integrin subtypes can influence downstream signaling 
cascades.  For example, ECs on CL preferentially activate PKA44 and eNOS45 in response 
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to laminar shear stress, when compared to ECs on FN.   Conversely, ECs adherent on FN 
display preferential activation of protein kinase C (PKC)42, PAK46, JNK47, 48, and NF-κB53.  
Activation of distinct signaling cascades can have profound effects on the cellular 
phenotype.  For instance, JNK and NF-κB are associated with pro-inflammatory signaling, 
indicating that FN-dependent signaling is correlated with inflammation and onset and 
progression of disease. Conversely, activation of eNOS is atheroprotective and anti-
inflammatory. 
In Chapter III, I demonstrated that ECs adherent on FN generate a mechanical 
response that includes stiffening and growth of focal adhesions in response to tension on 
PECAM-1, whereas ECs adherent on CL do not.  This difference in mechanical phenotypes 
is due to CL-specific activation of PKA and inactivation of RhoA. Interestingly, other vascular 
cell types have also shown matrix-specific mechanical responses. For instance, mechanical 
force has been applied to FN and CL-binding integrins in vascular smooth muscle cells 
(VSMCs) using AFM112.  In those studies, mechanical perturbation of FN-binding integrins 
induced a contractile response in VSMCs that is ROCK-dependent.  Conversely, when 
tension is applied to CL-binding integrins, the contractile response is absent (although other 
signaling events such as increased calcium influx remain intact).  Thus, there may be 
matrix-specific and force-dependent differences in RhoA activity in other vascular cell types 
as well.   
The data presented in Chapter III indicate that the presence of FN promotes a 
stiffening phenotype, whereas adhesion to CL promotes a more compliant phenotype. 
Interestingly, increased vascular stiffness has been associated with increased permeability 
and leukocyte infiltration, both of which are correlated with inflammation and vascular 
dysfunction.  Thus, my research also suggests that FN-dependent signaling promotes a pro-
inflammatory phenotype, while CL-dependent signaling may provide atheroprotective cues 
in the endothelium.   
	  	  
95	  
 
PKA in vascular biology. 
PKA is a multifunctional kinase that has many well-documented roles in cell biology.  
Importantly, the protein has also been implicated in numerous facets of vascular biology, 
including angiogenesis113, anti-inflammatory signaling44, and endothelial barrier function114, 
115.   Here, I will briefly summarize our knowledge of the role of PKA in vascular biology and 
summarize how my studies contribute to the field.  
ECs are central to angiogenesis, the process by which a new blood vessel arises 
from pre-existing vessels.  This process is tightly linked to cancer, as growth of new blood 
vessels not only provides oxygen and nutrients to the tumor, but also provides a means of 
escape during metastasis.  Angiogenesis is a complicated process that relies on dynamic 
EC interactions with the surrounding microenvironment.  Therefore, it is not surprising that 
integrins play a critical role in this process.  Indeed, integrin-dependent regulation of PKA 
has been shown to influence angiogenesis. In the context of cancer, ligation of α5β1 (a FN-
binding integrin) suppresses PKA activation, which increases EC survival and promotes 
angiogenesis113.  Data presented in Chapters II and III of this dissertation demonstrate that: 
1) Tension on PECAM-1 elicits α5β1 activation in ECs adherent on FN, and 2) ECs attached 
to FN do not activate PKA in response to force application on PECAM-1.  Thus, ligation of 
α5β1 downstream of mechanically activated PECAM-1 may also suppress PKA activation in 
the context of hemodynamic force. 
Another well-studied process in the vascular system is inflammation; a cellular 
process that contributes to numerous diseases, including atherosclerosis.  As previously 
mentioned, fluid shear stress plays a critical role in the development and progression of 
atherosclerosis, as flow-dependent and matrix-specific signaling have profound effects on 
pro/anti-inflammatory signaling in the endothelium.  Furthermore, matrix-specific activation 
of PKA has been shown to influence EC inflammation.  PKA is preferentially activated on CL 
in response to shear stress, and activation of the kinase inhibits pro-inflammatory signaling, 
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including activation of NF-κB.  Previous work has demonstrated that inhibition of PKA in vivo 
promotes pro-inflammatory signaling in the regions of the aorta where CL predominates44.  
Conversely, administration of iloprost, a prostacyclin analog that enhances adenylyl cyclase 
activity, in the FN-rich aortic arch (a region that is susceptible to pro-inflammatory signaling), 
decreases inflammation in vivo.  Thus, matrix-specific regulation of PKA activity has 
profound effects on EC inflammation in vivo. 
The work presented in Chapter III suggests that hemodynamic and matrix-specific 
activation of PKA also contribute to EC compliance in the CL-rich descending aorta.  
Vascular stiffness positively correlates with increased permeability and decreased barrier 
function55.  Therefore, activation of PKA and a more compliant cellular phenotype may serve 
as an atheroprotective mechanism that enhances barrier function.   PKA has been shown to 
decrease permeability and increase EC barrier function in previous studies.  Prostaglandin-
mediated activation of the kinase enhances adherens junction formation and decreases 
permeability in a cAMP/PKA-dependent manner via regulation of the Rho GTPase, Rac1114, 
115.  Furthermore, PKA-dependent RhoA phosphorylation enhances barrier function and 
prostaglandin-mediated PKA activation protects against thrombin-induced Rho activation 
and increased phosphorylated myosin light chain (pMLC) in ECs.  My data indicate that 
mechanically induced activation of PKA attenuates force-induced RhoA activation and 
promotes cell compliance, which may also influence EC barrier function and permeability in 
vivo. 
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INTEGRATING CHAPTERS II AND III:  MECHANISMS AND CONSEQUENCES OF EC 
STIFFENING. 
 
Shear stress and EC stiffness. 
  ECs are situated in a dynamic mechanical environment. Due to their unique location 
in the vessel, they are constantly exposed to hemodynamic forces produced by blood flow 
and must simultaneously regulate their own mechanical properties in order to resist shear 
forces.  Several studies have used various techniques to address the question of how fluid 
shear stress influences EC stiffness, and it is clear that a dynamic relationship between 
shear stress and EC stiffness exists over various timescales.  Using particle tracking of 
endogenous cellular vesicles, Dangaria et al demonstrated that laminar shear stress (10 
dyn/cm2) increases cytoplasmic compliance in as little as 30 sec, indicating that the 
cytoplasm softens upon exposure to shear58.  However, this response is short-lived as 
compliance returns to pre-shear levels within minutes.  However, one caveat of this study is 
that particle tracking of endogenous vesicles only provides insight in cytoplasmic stiffness, 
and therefore, excludes changes in mechanics of the cortical actin cytoskeleton. 
 Several studies have investigated cellular mechanics in response to shear stress 
over longer timescales.  Experimental evidence suggests that ECs that have been 
exposed to shear stress (2 Pa = 20 dyn/cm2) for 6 hours demonstrate similar mechanical 
properties as static ECs116, 117.  However, ECs become more resistant to AFM indentation 
between 6-24 hours of laminar shear, indicating an increase in cellular stiffness117.  Taken 
together, the literature suggests biphasic regulation of EC mechanics in response to fluid 
shear stress.  ECs immediately soften upon exposure to shear, but compliance returns to 
pre-shear values upon minutes to hours flow stimulation.  However, at timescales longer 
than 6hrs, ECs stiffen when compared to static cells. 
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 Interestingly, flow-induced changes in EC stiffness coincide with shear-dependent 
changes in Rho activity and cytoskeletal reorganization.  RhoA activity decreases within 5 
minutes upon shear stress stimulation, and within this short window, there is a significant 
breakdown of actin filaments43.  Interestingly, it is during this time that an increase in 
cellular compliance has been reported58.  Furthermore, the timescale in which flow-
induced increases in EC stiffness have been documented also coincide with the 
emergence of actin stress fibers that align in the direction of flow43, 117, 118.  These data 
suggest that changes in RhoA activity and reorganization of the actin cytoskeleton may 
contribute to shear-dependent changes in EC mechanics.  Therefore, future experiments 
investigating flow-dependent changes in RhoA activity and EC compliance may provide 
insights into the molecular mechanisms linking shear stress and EC mechanics. 
Previous work has also highlighted a complex relationship between hemodynamic 
force and cellular stiffness.   Effects on cellular stiffness are dependent on both shear 
stress magnitude and duration.  For instance, ECs exposed to 10 dyn/cm2 shear stress 
show little change in stiffness after 30 minutes of stimulation, but show a 3-fold increase 
in stiffness compared to static counterparts at later time points119.  Conversely, high shear 
stress magnitudes (~85 dyn/cm2) influence cellular stiffness in as little as 30-90 min, as 
ECs exposed to high shear stress magnitudes within this short time frame show a 4-fold 
increase in stiffness compared to static ECs119.  Furthermore, shear-induced EC stiffness 
is anisotropic within a single cell, such that the downstream edge of the cell is more 
compliant than the upstream edge of the cell (albeit still stiffer than a static cell)118.  Thus, 
while shear stress and EC mechanics are clearly related, the relationship between the 
two is complex and influenced by a number of dynamic variables. 
 While many studies have begun to address the relationship between shear and 
EC stiffness, many questions remain.  For instance, the influence of the extracellular 
matrix has not yet been explored in shear-induced EC stiffness, as all of the studies 
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performed to date have investigated responses in EC adherent on FN. Furthermore, 
investigating shear-induced EC stiffness on other matrices may be important, as the data 
presented in this dissertation suggest that the ECM composition has a profound effect on 
EC responsiveness to hemodynamic force.  In addition, studies to date have not yet 
investigated the influence of shear stress patterns (laminar vs. oscillatory) on EC 
stiffness, as all studies to date have compared EC stiffness in static cells versus ECs 
subjected to laminar shear. One may hypothesize that laminar or oscillatory shear stress 
may have different effects on EC mechanics.  In support of this hypothesis, a recent 
study suggests that laminar and oscillatory shear stress have divergent effects on EC 
intracellular tension120.  
 Finally, shear-induced effects on EC stiffness in vivo remain largely unexplored.  
One study performed in the late 1990s investigated how dynamic changes in shear stress 
influence focal adhesion components and cytoskeletal organization.  In this study, 
hemodynamics were altered in vivo by restricting the diameter of the aorta via the 
surgical model of coarctation in guinea pigs.  This surgery alters both shear stress 
patterns and magnitudes in the coarctation zone121.  Interestingly, ECs in the coarctation 
zone displayed more prominent stress fibers and increased focal adhesion size and 
number122.  While changes in EC stiffness were not evaluated in the study, my data 
suggest that increased focal adhesion size and number corresponds with EC stiffening13.   
Some studies have measured vessel wall stiffness in various regions of the 
vasculature using atomic force microscopy57, 123.  However, using this method, it is difficult 
to isolate EC stiffness, as mechanical properties of the underlying layers of the vessel are 
the major contributors to the measured compliance. I used external microbead passive 
rheology in order to measure EC stiffness in freshly isolated aortas and demonstrated 
that PKA influences EC compliance in the CL-rich descending aorta. However, a 
comprehensive understanding of EC mechanics in the heterogeneous environment in 
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vivo remains elusive.  Based on the findings in Chapter II and III, I hypothesize that ECs 
in the aortic arch (a region of the vasculature with high FN content) would be stiffer than 
ECs in the CL-rich descending aorta, and external microbead passive rheology will be 
used in future experiments in order to test this hypothesis.  However, it is important to 
remember that the aortic arch and descending aorta also differ in their hemodynamic 
environment, which may confound interpretation of results.  Thus, as previously noted, 
there is a need to understand the influence of shear stress patterns and ECM 
composition on EC mechanics in vitro in order dissect their respective contributions to EC 
stiffness in vivo. 
 
EC stiffening and vascular pathologies. 
 While studies linking shear stress and EC stiffness in vivo are lacking, numerous 
studies have identified a link between EC stiffness and decreased cardiovascular health.  
For instance, EC stiffness (as well as overall vessel stiffness) often increases in 
hypertensive vessels.  Stimulation of ECs with exogeneous extracellular sodium or 
aldosterone, a hormone that influences blood pressure by promoting sodium retention, 
induces an immediate and prolonged increase in EC stiffness54, 124.  Interestingly, this 
increase in EC stiffness has a functional effect as well, as ECs stimulated with sodium or 
aldosterone exhibit decreased NO production in vitro and blunted flow-mediated dilation 
in vivo54. 
 Increased EC stiffness has also been linked to hypercholesterolemia, a condition 
that contributes to vascular pathologies such as atherosclerosis and chronic 
inflammation.  Vascular inflammation can be influenced by oxidative damage of low 
density lipoprotein (LDL), and increased levels of oxidized LDL (oxLDL) have been linked 
to endothelial dysfunction and atherosclerotic plaque formation125.  OxLDL treatment 
increases EC stiffness in vitro and is associated with a concomitant increase in EC 
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intracellular force generation126.  In addition, ECs isolated from hypercholesterolemic pigs 
(which display increased oxLDL levels) are stiffer than control ECs isolated from healthy 
pigs126, suggesting that oxLDL also affects EC stiffness in vivo. Furthermore, increased 
cellular stiffness may also affect EC responsiveness to fluid shear stress.  Previous 
studies have indicated that ECs treated with oxLDL and exhibiting increased stiffness:  1) 
do not change morphology when subjected to shear, 2) show significant detachment from 
the substrate, and 3) display a 30% decrease in intercellular tension when under fluid 
shear stress127.  Therefore, EC stiffness may affect flow-mediated processes that are 
critical for vascular homeostasis.  
 Finally, age-related intimal stiffening has also been associated with increased EC 
permeability and leukocyte transendothelial migration55.  Furthermore, stiffness-induced 
EC permeability is ROCK-dependent, and inhibition of the kinase restores EC barrier 
function in vitro and reduces leukocyte transendothelial migration in vivo.  Interestingly, 
PECAM-1-mediated adaptive stiffening is also ROCK-dependent.  Thus, it may be 
interesting to investigate if PECAM-1-mediated adaptive stiffening also influences EC 
permeability and leukocyte transendothelial migration in vivo in future studies. 
Taken together, the literature clearly indicates that EC stiffness is associated with 
numerous pathologies and can be induced by various stimuli.  My work suggests that 
PECAM-1-mediated mechanosignaling and fluid shear stress influence mechanical 
responsiveness to hemodynamic force and EC stiffness in vitro and in vivo.  Previous 
studies have implicated hemodynamic force, extracellular matrix-specific signaling, and EC 
stiffness as contributors to cardiovascular disease.  However, the molecular mechanisms 
connecting these factors have not been identified.  My work highlights the EC 
mechanosensor PECAM-1 as a critical regulator of hemodynamic and ECM-specific EC 
stiffening in vitro and in vivo, thus providing a link to connect these three factors.  
Furthermore, the work presented here provides new insights into how mechanosensitive 
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signaling influences the EC phenotype and cardiovascular health and highlight PECAM-1-
mediated mechanotransduction as a critical regulator of EC biology and cardiovascular 
physiology.	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